Medicinal chemistry Books

Book SynopsisThe market-leader in medicinal chemistry: clear, supportive, and practical. It helps students to effortlessly make the link from theory to real-life applications using practical and focused coverage alongside a package of supportive online resources.Trade ReviewThe best general undergraduate textbook on medicinal chemistry. This new edition retains the accessible style of writing, but provides important updates on the topics. * Dr Mark Ashton, School of Pharmacy, Newcastle University, UK *I read this masterpiece to build a strong knowledge of medicinal chemistry and it has helped me a lot. I would definitely recommend it to others. Detailed explanations of enzyme-substrate interactions and much more are very useful. * Jinkal Gondaria, MChem student, Manchester Metropolitan University, UK *A very useful medical chemistry book and teaching tool. Great learning resources and easy to digest content. * Dr Silvia M.M.A. Pereira-Lima, Department of Chemistry, University of Minho, Portugal *Table of Contents1: Drugs and Drug Targets 2: Protein Structure and Function 3: Enzymes: Structure and Function 4: Receptors: Structure and Function 5: Receptors and Signal Transduction 6: Nucleic Acids: Structure and Function 7: Enzymes as Drug Targets 8: Receptors as Drug Targets 9: Nucleic Acids as Drug Targets 10: Miscellaneous Drug Targets 11: Pharmacokinetics and Related Topics Case Study 1: Statins 12: Drug Discovery: Finding a Lead 13: Drug Design: Optimizing Target Interactions 14: Drug Design: Optimizing Access to the Target 15: Getting the Drug to Market Case Study 2: The Design of ACE Inhibitors Case Study 3: Artemisinin and Related Antimalarial Drugs Case Study 4: The Design of Oxamni Case Study 5: Fosfidomycin as an Antimalarial Agent 16: Combinatorial and Parallel Synthesis 17: In Silico Drug Design 18: Quantitative Structure-Activity Relationships Case Study 6: De Novo Design of a Thymidylate Synthase Inhibitor 19: Antibacterial Agents 20: Antiviral Agents 21: Anticancer Agents 22: Protein Kinase Inhibitors as Anticancer Agents 23: Antibodies and Other Biologics 24: Cholinergics, Anticholinergics, and Anticholinestarases 25: Drugs Acting on the Adrenergic Nervous System 26: The Opioid Analgesics 27: Anti-Ulcer Agents 28: Cardiovascular Drugs Case Study 7: Steroidal Anti-Inflammatory Agents Case Study 8: Design of a Novel Antidepressant Case Study 9: The Design and Development Of Aliskiren Case Study 10: Factor Xa Inhibitors Case Study 11: Reversible Inhibitors of HCV NS-34A Protease

Read more less

Book Synopsis1: Chemical Bonding and Molecular Structure.- 2: Stereochemistry, Conformation, and Stereoselectivity.- 3: Structural Effects on Stability and Reactivity.- 4: Nucleophilic Substitution.- 5: Polar Addition and Elimination Reactions.- 6: Carbanions and Other Carbon Nucleophiles.- 7: Addition, Condensation and Substitution Reactions of Carbonyl Compounds.- 8: Aromaticity.- Aromatic Substitution.- 9: Concerted Pericyclic Reactions.- 10: Free Radical Reactions.- 11: Photochemistry.Trade ReviewFrom the reviews of the fifth edition:“Carey and Sundberg had written the most detailed and briliant account in the subject of organic chemistry. … The book provides an abundance of reaction examples organized in schemes. It makes studying very effective and helpful. … Advanced undergraduates and graduate students will welcome this new edition and the depth of materials covered.” (Philosophy, Religion and Science Book Reviews, bookinspections.wordpress.com, May, 2014)Table of ContentsChemical Bonding and Molecular Structure.- Stereochemistry, Conformation, and Stereoselectivity.- Structural Effects on Stability and Reactivity.- Nucleophilic Substitution.- Polar Addition and Elimination Reactions.- Carbanions and Other Carbon Nucleophiles.- Addition, Condensation and Substitution Reactions of Carbonyl Compounds.- Aromaticity.- Aromatic Substitution.- Concerted Pericyclic Reactions.- Free Radical Reactions.- Photochemistry.

Read more less

Book SynopsisIn Cannabis Is Medicine, medical cannabis specialist Bonni Goldstein, MD, explains the science behind the use of this amazingly therapeutic plant and describes in easy-to-understand detail the recently discovered endocannabinoid system, involved in almost every human physiological process. Over 4 million people in the US are healing difficult-to-treat illnesses with cannabis medicine, and although 33 states have medical cannabis laws, many physicians remain reluctant to discuss how this plant may be beneficial to health. this book is the comprehensive resource for patients and their loved ones who have not found answers with conventional medicines.Dr Goldstein has helped thousands of suffering patients -- including children -- find relief with cannabis. In her revelatory book, she explains the current state of scientific research on more than 28 chronic medical conditions that have responded positively to treatment with cannabis, and offers actionable adTrade ReviewDr. Goldstein sets the record straight on cannabis, offering an in-depth, scientific look at the potent healing power of this much-maligned plant. Anyone considering cannabis medicine for themselves or a loved one needs to read this book. * Mark Hyman, MD, author of Food: What the Heck Should I Eat? *Cannabis Is Medicine tells it like it is. For far too long the important medicinal potential of the cannabis plant has been at least overlooked, and at worst, aggressively stigmatized. The incredible potential of cannabis derivatives across a wide panorama of medical conditions is now widely embraced by highly respected science. And Dr. Bonni Goldstein has done a magnificent job of eloquently presenting this science to augment our tools as healthcare providers as well as for consumers at large. A powerful validation of the healing properties of cannabis. * David Perlmutter, MD, bestselling author of Grain Brain and Brain Wash *

Read more less

Book SynopsisTHE PHENOMENAL SUNDAY TIMES BESTSELLER ''Science writing at its best. If only chemistry had been like this at school'' Matt Ridley ____________________ Everything in the universe is made of them, including you. Like you, the elements have personalities, attitudes, talents, shortcomings, stories rich with meaning. Here you''ll meet iron that rains from the heavens and noble gases that light the way to vice. You''ll learn how lead can tell your future while zinc may one day line your coffin. You''ll discover what connects the bones in your body with the Whitehouse in Washington, the glow of a streetlamp with the salt on your dinner table. Unlocking their astonishing secrets and colourful pasts, Periodic Tales is a voyage of wonder and discovery, showing that their stories are inextricable from the stories of our own lives. ____________________ ''A love letter to the chemical elements. Aldersey-Williams is full of good stories and he knows how to tell them well'' Sunday Telegraph ''The history, science, art, literature and everyday applications of all the elements from aluminium to zinc'' The Times ''Great fun to read and an endless fund of unlikely and improbable anecdotes'' Financial TimesTrade ReviewScience writing at its best ... fascinating and beautiful ... if only chemistry had been like this at school ... to meander through the periodic table with him ... is like going round a zoo with Gerald Durrell ... a rich compilation of delicious tales, but it offers greater rewards, too -- Matt RidleyImmensely engaging and continually makes one sit up in ­surprise * Sunday Times *Splendid ... enjoyable and polished * Observer *Full of good stories and he knows how to tell them well ... an agreeable jumble of anecdote, reflection and information * Sunday Telegraph *Great fun to read and an endless fund of unlikely and improbable anecdotes ... sharp and often witty * Financial Times *A joyous romp through the chemical elements * Today, BBC Radio 4 *Not only a cultural history of the elements, it is also a lament to the loss of science as a hobby * Economist *A flashily brainy book, crammed with literary references and held together by a personal quest to collect as many elements as possible * Telegraph *'Elements are fun' is the essential premise of Hugh Aldersey-Williams's new book and by heck he's right ... Aldersey-Williams mourns the fact chemistry isn't really sexy any more; Periodic Tales is a step towards it getting its mojo back * Metro **** *Imaginative and fun ... almost every page yields a nugget * Nature *

Read more less

Book SynopsisAlkylation of Enolates and Other Carbon Nucleophiles.- Reactions of Carbon Nucleophiles with Carbonyl Compounds.- Functional Group Interconversion by Substitution, Including Protection and Deprotection.- Electrophilic Additions to Carbon-Carbon Multiple Bonds.- Reduction of Carbon-Carbon Multiple Bonds, Carbonyl Groups, and Other Functional Groups.- Concerted Cycloadditions, Unimolecular Rearrangements, and Thermal Eliminations.- Organometallic Compounds of Group I and II Metals.- Reactions Involving Transition Metals.- Carbon-Carbon Bond-Forming Reactions of Compounds of Boron, Silicon, and Tin.- Reactions Involving Carbocations, Carbenes, and Radicals as Reactive Intermediates.- Aromatic Substitution Reactions.- Oxidations.- Multistep Syntheses.Trade ReviewFrom the reviews of the fifth edition: "Advanced Organic Chemistry … the well-known textbook for graduate students – has now appeared in a 5th edition. … Carey & Sundberg will be interesting to all students who seek a detailed understanding of organic chemistry, and who wish to refresh and embellish their existing knowledge. On the strength of the scope and quality of the explanations, this pair of texts is recommended for use as the resource of first resort for specific research questions in one’s later career." (www.organische-chemie.ch, January, 2008)Table of ContentsAlkylation of Enolates and Other Carbon Nucleophiles.- Reactions of Carbon Nucleophiles with Carbonyl Compounds.- Functional Group Interconversion by Substitution, Including Protection and Deprotection.- Electrophilic Additions to Carbon-Carbon Multiple Bonds.- Reduction of Carbon-Carbon Multiple Bonds, Carbonyl Groups, and Other Functional Groups.- Concerted Cycloadditions, Unimolecular Rearrangements, and Thermal Eliminations.- Organometallic Compounds of Group I and II Metals.- Reactions Involving Transition Metals.- Carbon-Carbon Bond-Forming Reactions of Compounds of Boron, Silicon, and Tin.- Reactions Involving Carbocations, Carbenes, and Radicals as Reactive Intermediates.- Aromatic Substitution Reactions.- Oxidations.- Multistep Syntheses.

Read more less

Book SynopsisThe description and analysis of the Mexican and other countries desertic plants from the point of view of their use in traditional medicine and their potential use in integrative medicine is the overall theme of this book. Aromatic and Medicinal Plants of Drylands and Deserts: Ecology, Ethnobiology and Potential Uses describes the historic use of drylands plants, botanical and geological classification, also describes the endemic plants used in traditional medicine, going through the most relevant aspects of biomedicine and integrative medicine. The chemical and bioactive compounds from desertic medicinal and aromatic plants and the analytic techniques to determine chemical and bioactive compounds from the medicinal and aromatic plants are reviewed. Ethnobiology is detailed in the present book as well as the importance of the integrative medicine for the ancient and actual cultures. The book represents an effort to keep the ethnobiological knowledge of communities for the use of traTable of ContentsPrefaceChapter 1 Introduction to plant taxonomy: vascular and non-vascular plants with medicinal use. Muro-Pérez G., Sánchez-Salas J., Cano-Villegas O., López-García R., Valenzuela-Núñez L. M.Chapter 2 Mexican desertic medicinal plants: biology, ecology, and distribution. Hernández-Herrera J. A., Valenzuela-Núñez L. M., Encina-Domínguez J. A., Martínez-Sifuentes A. R., Lara-Reimers E. A., Navarrete-Molina C.Chapter 3 Mexican Desert: Health and biotechnological properties potential of some cacti species (Cactaceae). Trujillo J., Pérez-Miranda S., Ramírez-Hernández A., Muñiz-Ramírez A., García-Campoy A.H., Ramírez-Rodríguez Y. Chapter 4 Potential of plants from the arid zone of Coahuila in Mexico for the extraction of essential oils. Solís-Quiroz O. S., González-Machado A. C., Aguirre-Joya J. A., Aguillón-Gutiérrez D. R., Ramírez-Moreno A., Torres-León C.Chapter 5 Ethnopharmacology of important Aromatic Medicinal plants of the Caatinga, Northeastern Brazil. Olaitan-Balogun S., Medeiros-Bandeira M. A., do Nascimento-Magalhães K., Lima-Soares I. Chapter 6 Plants of the Chihuahuan Semi-desert for the Control of Phytopathogens. Cándido-del Toro C. A., Arredondo-Valdés R., Govea-Salas M., Anguiano-Cabello J. C., Segura-Ceniceros E. P., Ramos-González R., Ascacio-Valdés J. A., Laredo Alcalá E. I., Iliná A.Chapter 7 Phytochemical compounds from desert plants to management of plant-parasitic nematodes. Marco Tucuch-Pérez A., Arredondo-Valdés R., Hernández-Castillo F. D., Ochoa-Fuentes Y. M., Laredo Alcalá E. I., Anguiano-Cabello J. C.Chapter 8 Plant phytochemicals from the Chihuahuan semi-desert with possible herbicidal actions. Barroso-Ake A. C., Arredondo-Valdés R., Ramos-González R., Laredo-Alcalá E. I., Aguilar-González C. N., Ascacio-Valdés J. A., Govea-Salas M., Iliná A., Tucuh-Peréz M. A.Chapter 9 ¬Chemical and bioactive compounds from Mexican desertic medicinal plants. López-Romero J. C., Torres-Moreno H., Ireta-Paredes A. R., Charles-Rodríguez A. V., Flores-López M. L.Chapter 10 Edible coating based on chia (Salvia hispanica L.) functionalized with Rhus microphylla fruit extract to improve the cucumber (Cucumis sativus L.) shelf life. Charles-Rodríguez AV., Reyes-de la Luz M., Guía-García J. L., Peña-Ramos F.M., Robledo-Olivo A., Hench-Cabrera A. F., Flores-López M. L.Chapter 11 Larrea tridentata: bioactive compounds, biological activities and its potential use in phytopharmaceuticals improvement. López-Romero J. C., Torres-Moreno H, Rodríguez-Martínez K. L., Suárez-García A. del C., Beltrán-Martínez M. E., García-Dávila J.Chapter 12 Toxicological aspects of medicinal plants that growth in drylands and polluted environments. Pérez-Morales R., Téllez López M. A., Olivas Calderón E. H., González-Zamora A.

Read more less

Book SynopsisTable of ContentsAbout the Author xvii Foreword xix Preface xxi Acknowledgments xxv About the Companion Website xxvi 1 Knowing What to Expect: Hazards, Vulnerability, and Disasters 1 2 Understanding the Actors: Roles and Responsibilities of Relevant Stakeholders 53 3 Anticipating Attitudes and Behavior in Disasters: Myths, Exaggerations, and Realities 93 4 Applying Alternative Management Approaches: Disaster Response and Recovery Theory 123 5 Implementing Initial Response Measures: Hazard Detection, Warning, Evacuation and Sheltering 149 6 Caring For the Injured, Dead, and Distraught: Overcoming Physical and Emotional Impacts 191 7 Managing Public Information, Donations, and Volunteers: Expected Difficulties and Benefits 237 8 Moving Beyond Immediate Needs: Damage Assessment, Disaster Declarations, and Debris Removal 277 9 Promoting Recovery and Mitigation: Disaster Assistance, Rebuilding, and Vulnerability Reduction 317 10 Overcoming Typical Challenges: Vital Considerations for Response and Recovery 357 11 Harnessing Technology and Organization: Tools and Structures for Effective Operations 407 12 Foreseeing the Future: Prior Lessons, Unaddressed Risks, and Rising Vulnerability 455 13 Enhancing Disaster Resilience: Preparedness, Improvisation, Spontaneous Planning, Leadership, and Professionalism 517 Index 559

Read more less

Book SynopsisWelcome to Dopeworld. Ecstasy in London, crack in Los Angeles, LSD in Tokyo, heroin in Sofia, cocaine in Medellin, bounty hunting in Manilla, opium in Tehran. Get ready for your next fix. __________Dopeworld is a bold and intoxicating journey into the world of drugs. From the cocaine farms in South America to the streets of Manila, we trace the emergence of psychoactive substances and our intimate relationship with them. With unparalleled access to drug lords, cartel leaders, street dealers and government officials, Niko Vorobyov attempts to shine a light on the dark underbelly drug world.At once a bold piece of reportage and a hugely entertaining and perverse travelogue, Dopeworld reveals how drug use is at the heart of our history, our lives, and our world.__________ With echoes of Gomorrah and Fear and Loathing in Last Vegas, Dopeworld is a brilliant and enlightening journey across the world, examining every angle of the drug war.

Read more less

Book SynopsisSpace Pharmacology is a review of the current knowledge regarding the use of pharmaceuticals during spaceflights. Every section begins with a topic overview, and is followed by a discussion of published data from spaceflight, and from ground experiments meant to model the spaceflight situation.Table of ContentsChapter 1: Introduction.- Chapter 2: Absorption.- Chapter 3: Distribution.- Chapter 4: Metabolism and Excretion.- Chapter 5: Central Nervous System.- Chapter 6: Cardiovascular System.- Chapter 7: Gastrointestinal System.- Chapter 8: Musculoskeletal System.- Chapter 9: Multiple Systems Spaceflight Effects.- Chapter 10: Conclusions - Special Challenges of Long Duration Exploration.- References.- Abbreviations.

Read more less

Book SynopsisCompletely revised and updated, the 2nd edition of The Handbook of Medicinal Chemistry draws together contributions from authoritative practitioners to provide a comprehensive overview of the field as well as insight into the latest trends and research. An ideal companion for students in medicinal chemistry, drug discovery and drug development, while also communicating core principles, the book places the discipline within the context of the burgeoning platform of new modalities now available to drug discovery. The book also highlights the role chemistry has to play in wider target validation and translational technologies. This is a carefully curated compilation of writing from global experts using their broad experience of medicinal chemistry, project leadership and drug discovery and development from an industry, academic and charity perspective to provide unparalleled insight into the field.Table of ContentsPhysicochemical Properties; Synthesis in Medicinal Chemistry; Useful Computational Chemistry Tools for Medicinal Chemistry; Structure-based Design for Medicinal Chemists; Fragment-based Ligand Discovery; Machine Learning in Drug Design; Drug Metabolism; ADME Optimization in Drug Discovery; Molecular Biology for Medicinal Chemists; Assays; In Vitro Biology: Measuring Pharmacological Activity That Will Translate to Clinical Efficacy; Animal Models: Practical Use and Considerations; Bioinformatics for Medicinal Chemistry; Translational Science; Discovery Toxicology in Lead Optimization; Toxicology and Drug Development; Patents for Medicines; Target Validation for Medicinal Chemists; Lead Optimisation: What you should know!; Pharmaceutical Properties – The Importance of Solid Form Selection; The Medicinal Chemistry and Process Chemistry Interface; Clinical Drug Development; SMN2 Splicing Modification by Small Molecules – A Blueprint to Tackle the Underlying Genetic Cause of Many Underserved Diseases; The Discovery of Checkpoint Kinase 1 Inhibitors: From Fragments to Clinical Candidate; Medicinal Chemistry for Neglected Diseases – Malaria, Tuberculosis, Sleeping Sickness, Leishmaniasis and River Blindness; New Therapeutic Chemical Modalities: Compositions, Modes-of-action, and Drug Discovery

Read more less

Book SynopsisThis book provides a fundamental understanding of immunopathology and immunopathologic processes, with particular attention to nonclinical toxicology studies. Chapters provide organ system–based summaries of spontaneous pathology and common responses to xenobiotics. A companion volume, Immunopathology in Toxicology and Drug Development: Volume 1, Immunobiology, Investigative Techniques, and Special Studies, offers an overview of general immunobiology, cells of the immune system, signaling and effector molecules, and immunopathology assays. These informative and strategic books were created in response to the large segment of drug development that focuses on chronic diseases, many of which involve alterations to the immune system. Therapies that target these diseases commonly involve some form of immunomodulation. As a result, the two volumes of Immunopathology in Toxicology and Drug Development are critical texts for individuals involved in diverse aspects of drug development. Readers will acquire a thorough understanding of immunopathology for detection and accurate interpretation of pathologic effects of xenobiotics on the immune system. Trade Review“The purpose is to provide organ system-based summaries of spontaneous pathology and common responses to xenobiotics. … used as a textbook or reference for students, as an informative resource for novices in the field, and as a reference for researchers in the immune toxicology field. It also can be educational for the lay public who are interested in learning immunopathology in xenobiotics or general basic immunology. … a terrific book that I will certainly integrate into my graduate teaching.” (Hongmin Ni, Doody's Book Reviews, November, 2017)Table of ContentsThymus.- Spleen.- Lymph node.- Mucosa-associated lymphoid tissues.- Immunopathology of the nervous system.- Immunopathology of the urinary system.- Immunopathology of the hepatobiliary system.- Immunopathology of the respiratory system.- Immunopathology of the cardiovascular system.- Immunopathology of the male reproductive tract.- Immunopathology of the female reproductive tract and mammary gland.- Immunopathology of the musculoskeletal system.- Immunopathology of the endocrine system.- Ocular Immunopathology.- Immunopathology of Drug and Toxin-related Skin Reactions.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

a huge range and FREE tracked UK delivery on ALL orders.

Read more less

Book SynopsisAnalyses for naturally occurring biological substances or administered materials have been with us for many years. These were usually based on the physical or chemical characteristics of the substances to be measured. However in recent years there has been an explosion of interest in analytical methods which made use of the high specificity and sensitivity of im­ munological reactions. These methods can be very simple in terms of technical procedures and can usually be performed on minute samples of biological fluids - factors which have ensured their ready acceptance in most laboratories. Recently there have been numerous meetings on technical aspects of particular immunoassays and on their application in specific diseases. We felt however that the time was ripe for an 'overview' of the whole field. To this end a conference on 'Immunoassays for the 80s' was held at the Zoological Society of London in 1980, and this book is largely based on that meeting. Both the immunoassay techniques and their numerous applications were discussed and are dealt with at length in this volume. The editors wish to thank all the contributors for their chapters and to acknowledge the debt they owe to Jean Ryan (NLCM) without whose organization and assistance this volume would not have been completed. A.V., D.B., A.B.Table of ContentsI Immunoassay Techniques.- 1. Historical perspectives.- 2. Merits and disadvantages of different labels and methods of immunoassay.- 3. Assays utilizing red cells as markers.- 4. Particle counting immunoassay (PACIA): an automated non-radioisotopic immunoassay method, suitable for antigens, haptens, antibodies and immune complexes.- 5. Precipitation and related immunoassay techniques.- 6. Radioimmunoassay.- 7. Heterogeneous enzyme immunoassays.- 8. Immunoassays employing reactants labelled with a fluorophore.- 9. Chemiluminescence and its use in immunoassay.- 10. New homogeneous assay methods for the determination of proteins.- 11. Antisera in immunoassays with special reference to monoclonal antibodies to human immunoglobulins.- 12. External quality assessment schemes for immunoassays.- 13. The control of performance in immunoassays.- 14. Components in a model for the production of reference materials with special reference to immunoassays.- 15. Standardization of immunological reagents.- II Applications of Immunoassays.- 16. Steroid immunoassays in endocrinology.- 17. Immunoassays in pharmacology and toxicology.- 18. Immunoassays in autoimmune disease.- 19. Radioimmunoassays in allergy.- 20. Immunoassay screening for open neural-tube defects: practical aspects.- 21. Immunoassays in haematology.- 22. Immunoassays in tissue typing.- 23. Immunoassays for acute phase proteins.- 24. Rapid virus diagnosis.- 25. Viral hepatitis with special reference to hepatitis B.- 26. Immunoassays for hepatitis A.- 27. Immunoassays for the TORCH programme.- 28. Current status of specific IgM antibody assays.- 29. Enzyme immunoassays in bacteriology.- 30. Immunoassays in mycology.- 31. Some applications of immunoassays in tropical parasitic infections.- 32. Immunoassays in veterinary medicine.- 33. Immunoassays in plant virology.

Read more less

Book SynopsisPrevention of renal disease: an overview.- Evaluation and significance of renal functional reserve in health and disease.- Angiotensin I: Converting enzyme inhibition in models of progressive glomerulosclerosis.- Prevention of nephrotoxicity of beta-lactam antibiotics.- Prevention of analgesic nephropathy.- Efficacy and nephrotoxicity of aminoglycoside.- Prevention of cadmium and lead nephropathy.- Prevention of bone disease in renal failure.- Kidney function, hypertension and clinical diabetic nephropathy in type I diabetes.- Drug management of hyperlipidemia.- Index of subjects.Table of ContentsPrevention of renal disease: an overview.- Evaluation and significance of renal functional reserve in health and disease.- Angiotensin I: Converting enzyme inhibition in models of progressive glomerulosclerosis.- Prevention of nephrotoxicity of beta-lactam antibiotics.- Prevention of analgesic nephropathy.- Efficacy and nephrotoxicity of aminoglycoside.- Prevention of cadmium and lead nephropathy.- Prevention of bone disease in renal failure.- Kidney function, hypertension and clinical diabetic nephropathy in type I diabetes.- Drug management of hyperlipidemia.- Index of subjects.

Read more less

Table of ContentsThe 23rd Annual Symposium of the SSIEM: Liverpool.- to recombinant DNA.- Human biochemical genetics of enzyme proteins in the new age of molecular genetics.- Direct DNA analysis in family studies.- Application and limitations of direct DNA analysis in genetic prediction.- DNA analysis for ornithine transcarbamylase deficiency.- Molecular genetics of PKU.- Human DNA repair defects.- Molecular basis of ai-antitrypsin deficiency and its potential therapy by gene transfer.- Direct alteration of a gene in the human genome.- Diabetes mellitus, atherosclerosis, and the 5’ flanking polymorphism of the human insulin gene.- Workshop on Screening for Congenital Adrenal Hyperplasia (steroid 21-hydroxylase deficiency).- Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.- Biochemical aspects of congenital adrenal hyperplasia.- Large-Scale Pilot Studies.- Review of CAH screening programmes and the Scottish experience.- Neonatal screening programme for congenital adrenal hyperplasia in a homogenous Caucasian population.- Neonatal screening for congenital adrenal hyperplasia: a pilot study in France.- Existing Clinical Diagnoses.- Congenital adrenal hyperplasia in Birmingham: a retrospective analysis (1958-1985).- Prevalence of adrenal 21-hydroxylase deficiency in neonates born in the West Midlands: a retrospective study.- Clinical Symposium - Phenylketonuria.- and explanation.- Maternal phenylketonuria.- Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function.- Diagnosis in relationship to treatment of hyperphenylalaninaemia.- Problems related to diet management of maternal phenylketonuria.- Short Communications.- Preface and Free Communications.- Molecular biology of phenylalanine hydroxylase.- Hepatic phenylalanine hydroxylase and dietary tolerance in hyperphenylalaninaemic patients.- Phenylalanine metabolites in treated phenylketonuric children.- Magnesium-deficient rickets in a phenylketonuric patient on dietary treatment.- Termination of strict diet in phenylketonuria: neurophysiological, psychological and biochemical studies.- Effects of stopping phenylalanine-restricted diet on intellectual progress of children with phenylketonuria.- Maternal hyperphenylalaninaemia: dietary treatment during pregnancy.- Maternal hyperphenylalaninaemia in Israel.- Maternal phenylketonuria with increased tyrosine supplements.- Screening for phenylketonuria in Yugoslavia (SR Croatia) 1979–1984.- Incidence of phenylketonuria and hyperphenylalaninaemia in a sample of the Turkish newborn population.- Atypical phenylketonuria with mild mental retardation caused by tetrahydrobiopterin deficiency in a Chinese family.- Dihydropteridine reductase deficiency: clinical, biochemical and therapeutic aspects.- Partial dihydropteridine reductase deficiency and mental retardation.- Urine amino acid analysis by HPLC in the investigation of inborn errors of metabolism.- Plasma amino acid patterns in critically ill children.- Treatment of hereditary tyrosinaemia (fumarylacetoacetase deficiency) by enzyme substitution.- Presentation of the data of the Italian registry for oculocutaneous tyrosinaemia.- A new case of hyperlysinaemia with saccharopinuria.- Failure of early diazepam treatment in a neonate with non-ketotic hyperglycinaemia.- Gyrate atrophy of the choroid and retina: 3 cases in one Italian family.- Methylenetetrahydrofolate reductase and methyltetrahydrofolate methyltransferase in human fetal tissues and chorionic villi.- Kinetic studies on the glucose-6-phosphate transport system in rat hepatic microsomal membrane.- Long term cornstarch therapy in glycogen storage disease types I, lb and III.- Galactose-l-phosphate-uridyl transferase activity in chorionic villi: a first trimester prenatal diagnosis of galactosaemia.- Molecular heterogeneity of McArdle disease.- Decreased affinity of phosphorylase ? for glucose-1 -phosphate in polymorphonuclear leukocytes of patients with glycogenosis type VI.- The diagnosis and treatment of a patient with medium-chain acyl-CoA dehydrogenase deficiency: overnight fasting does not result in the expected urinary metabolite profile.- A new case of familiar C6-C14 dicarboxylic aciduria with favourable evolution.- Pyruvate carboxylase responsive to ketosis in a multiple carboxylase deficiency patient.- Neonatal screening for biotinidase deficiency: an update.- GM2 gangliosidosis with hexosaminidase A and B defect: report of a family with motor neuron disease-like phenotype.- A comparison between hepatocytes and macrophages of sphingomyelin, cholesterol and acid lipase in various types of Niemann-Pick disease.- Juvenile dystonia without vertical gaze paralysis: Niemann-Pick type C disease.- Pre- and postnatal diagnosis of the cerebro-hepato-renal (Zellweger) syndrome via a simple method directly demonstrating the presence or absence of peroxisomes in cultured skin fibroblasts, amniocytes or chorionic villi fibroblasts.- Impaired cholesterol side chain cleavage activity in liver from patients with cerebro- hepato-renal (Zellweger) syndrome in relation to the accumulation of di- and trihydroxycoprostanoic acid in serum.- Deficiency of dihydroxyacetonephosphate acyltransferase and catalase-containing particles in patients with infantile Refsum’s disease.- Peroxisomal abnormalities in rhizomelic chondrodysplasia punctata.- Cytogenetic studies of three families with ataxia-telangiectasia (Louis-Bar syndrome).

Read more less

Book SynopsisThe first symposium of the Society for the Study ofInborn valuable overview of advances in the application of Errors of Metabolism (SSIEM) on the organic acid urias chemical analysis of amniotic fluid to their early prenatal was held in Leeds in 1971 and published by the Society in diagnosis. The continuing complexity of diagnosis, 1972 (the 9th Annual SSIEM Symposium). Although biochemistry and aetiology ofthe dicarboxylic acid urias relatively few of these disorders were recognized at that has been admirably reduced by the papers from Dr time, the symposium was prompted by the then recent Gregersen and Dr Goodman, with Dr Goodman clearly identification between 1966 and 1970 of isovaleric identifying the primary defect in the polycystic variant of acidaemia, methylmalonic aciduria, propionic aci- multiple acyl CoA dehydrogenase deficiency ("glutaric daemia, pyroglutamic aciduria and 3-methylcrotonyl- aciduria type II") as a deficiency of electron transfer glycinuria. Identification and diagnosis of diseases of this flavoprotein (ETF) dehydrogenase. Dr Engel's paper kind had greatly improved primarily through the also provides a useful overview from currently available application of gas chromatography and mass spectro- data of the place of L-carnitine in the organic acid urias, metry to medicine, although the complexity of the an area in which rapid developments are occurring. The underlying biochemistry and the genetic heterogeneity of emerging understanding of the aetiologies of the the organic acidurias was not then realised.Table of ContentsPreface.- Section I: Clinical aspects: management and outcome.- Neonatal management of organic acidurias. Clinical update (Hudson Memorial Lecture).- Long term outcome of organic acidurias: survey of 105 French cases (1967-1983).- The management and long term outcome of organic acidaemias.- Prenatal diagnosis of the organic acidurias.- Symptoms and signs in organic acidurias.- Section II: Dicarboxylic acidurias and acyl-CoA dehydrogenase deficiencies.- Fatty acyl-CoA dehydrogenase deficiency: enzyme measurement and studies on alternative metabolism.- Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency).- Carnitine metabolism and inborn errors.- Gas chromatography—mass spectrometry (GC—MS) diagnosis of 2 cases of medium chain acyl-CoA dehydrogenase deficiency.- The differential diagnosis of dicarboxylic aciduria.- Animal models for dicarboxylic aciduria.- Section III: Disorders of the respiratory chain and the lactic acidaemias.- Mitochondrial oxidative phosphorylation and respiratory chain: review.- Mitochondrial myopathies: disorders of the respiratory chain and oxidative phosphorylation.- Lactic acidaemia.- Pyruvate carboxylase deficiency.- Organic acids in urine of patients with congenital lactic acidoses: an aid to differential diagnosis.- Section IV: A new disorder: 4-hydroxybutyric aciduria.- Clinical review.- Biochemical findings.- Enzymology and mode of inheritance.- Section V: Short Communications.- Preface to Short Communications.- Free Communications.- Electron-transferring flavoprotein deficiency in the multiple acyl-CoA dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria.- Glutaric aciduria type II: multiple defects in isolated muscle mitochondria and deficient ?-oxidation in fibroblasts.- Glutaryl CoA dehydrogenase activity determined with intact electron-transport chain: application to glutaric aciduria type II.- Medium chain acyl-CoA dehydrogenase deficiency: apparent Km and Vmax values for fibroblast acyl-CoA dehydrogenase towards octanoyl-CoA in patient and control cell lines.- Mitochondrial myopathy with partial cytochrome oxidase deficiency and impaired oxidation of NADH-linked substrates.- L-Carnitine insufficiency in disorders of organic acid metabolism: response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria.- An evaluation of urine lactate for detection of inborn errors of metabolism.- Metabolic acidosis versus a compensation of respiratory alkalosis in four children with Leigh’s disease.- Chemical diagnosis of dihydrolipoyl dehydrogenase deficiency.- 3-Hydroxy-3-methylglutaric, 3-methylglutaconic and 3-methylglutaric acids can be non-specific indicators of metabolic disease.- Different organic acid patterns in urine and in cerebrospinal fluid in a patient with biotinidase deficiency.- Biotinidase deficiency: the possible role of biotinidase in the processing of dietary protein-bound biotin.- Biotin-responsive multiple carboxylase deficiency (MCD): deficient biotinidase activity associated with renal loss of biotin.- Organic acids in urine: sample preparation for GC/MS.- Experience with prenatal diagnosis of propionic acidaemia and methylmalonic aciduria.- Methylmalonic aciduria with homocystinuria.- Two cases of ß-ketothiolase deficiency: a comparison.- L-Glyceric aciduria (primary hyperoxaluria type 2) in siblings in two unrelated families.- The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC—MS assay for succinylacetone.- The enzyme defects in hereditary tyrosinaemia type I.- The possibility for prenatal diagnosis of PKU by linkage analyses based on phenylalanine hydroxylase locus specific DNA-polymorphisms.- Complementation between argininosuccinate synthetase-deficient and argininosuccinate lyase-deficient fibroblasts depends on intercellular communication.- Molecular lesion of non-ketotic hyperglycinaemia.- Prolidase deficiency: detection of cases by a newborn urinary screening programme.- Type Ib glycogen storage disease: an in vivo and in vitro study of two cases.- The lactate concentration of the urine, a parameter for the adequacy of dietary treatment of patients with glucose-6-phosphatase deficiency.- Sorbitol dehydrogenase deficiency in a family with congenital cataracts.- Thiamin-responsive megaloblastic anaemia: a disorder of thiamin transport?.- Acid esterase deficiency: comparison of biochemical findings in infantile and adult forms.- Steroid sulphatase deficiency. Steroid sulphatase and arylsulphatase C determination in normal and affected fibroblasts.- Steroid sulphatase deficiency is present in patients with the syndrome’ ichthyosis and male hypogonadism’ and with’ Rud syndrome’.

Read more less

Book SynopsisThe rapid growth of specific protein estimations in the clinical laboratory over the last 10 years has been due to advances both in methodology and in the understanding of the role of the various plasma proteins in health and disease. This expansion has been made possible by the development of both gel phase and fluid phase techniques for the estimation of proteins and the ready availability of antisera to individual plasma proteins. The specificity of the immunological reaction has allowed the more precise identification and estimation of individual plasma proteins than was possible with dye binding or other chemical techniques, but at the same time these methods have introduced other possible errors and pitfalls. Advances in understanding of the structure and function of various plasma proteins has pointed the way to new clinical applications of plasma protein estimation in the diagnosis and monitoring of disease. The Symposium, of which these are the proceedings, was planned to bring together a number of experts in the field to discuss the available methods and their clinical application.Table of ContentsSection One Methods and Problems in Immunochemistry.- 1 Electrophoresis and Immunoelectrophoresis.- 2 Radial immunodiffusion and rocket Immunoelectrophoresis.- 3 Automated immunoprecipitation and laser nephelometry.- 4 Antiserum requirements.- 5 Problems encountered in immunochemical technique methodology.- 6 Specific protein measurement and standardization.- 7 Quality control.- Section Two Specific Proteins in Laboratory Diagnosis.- 8 Structure and function of the immunoglobulins.- 9 Immunoglobulins in blood transfusion.- 10 Monoclonal proteins.- 11 Iron binding proteins.- 12 Albumin.- 13 The complement system.- 14 Alphafetoprotein in obstetrics.- 15 Alphafetoprotein in oncology.- 16 ?1-Antitrypsin.- 17 Haptoglobin and orosomucoid in lung and breast tumours.- Section Three Immunochemistry of Other Body Fluids.- 18 Urinary proteins.- 19 Immunochemistry of CSF proteins.- Discussion.

Read more less

Book SynopsisThis book exclusively focuses on the science and fundamentals of polymer gels, as well as the numerous advantages that polymer gel-based materials offer. It presents a comprehensive collection of chapters on the recent advances and developments in the core science and fundamentals of both synthetic and natural polymer-based gels, and pays particular attention to applications in the various research fields of biomedicine and engineering. Key topics addressed include: polysaccharide-based gels and their fundamentals; stimuli-responsive polymer gels; polymer gels applied to enzyme and cell immobilization; chitosan-based gels for cancer therapy; natural polymeric and gelling agents; radiation dosimetry; polymeric gels as vehicles for enhanced drug delivery across the skin; transport in and through gel; and polymer gel nanocomposites and functional gels. The book’s extensive and highly topical coverage will appeal to researchers working in a broad range of fields in industry and academia alike.Table of ContentsBrea Gum Gel Capacity.- An Overview on Polymer Gels Applied to Enzyme and Cell Immobilization.- Xylan-Based Gels and Their Fundamentals.- Stimuli-Responsive Polymer Gels for Protein Delivery.- Polysaccharide-Based Polymergels.- Chitosan Based Gels for Cancer Therapy.- Natural Polymeric and Gelling Agents.- Radiation Dosimetry - A Different Prospective of Polymer Gel.- Polymeric Gels: Vehicles for Enhanced Drug Delivery Across Skin.- Graphene Oxide - Polymer Gels.- Transport in and Through Gel.- Strategizing Advance Application of Polymer Gels by Incorporation of Fillers.- Polymer Gels: New Materials for the Future.- Polymer Gel-Clay (Nano)Composites.- Functional Gels.- Molecular Distinction Between Structures of Nanoporous Siloxane Polymers.- Stimuli Responsive Polysaccharides Based Gels: Fundamental and Pharmaceutical Aspects.- Polymer Gel for Islet Encapsulation for Diabetes Therapy.

Read more less

Book SynopsisIMPACTS OF THE COVID-19 PANDEMIC Enables Readers to Understand the Impact of International Legislative and Policy Responses to the COVID-19 Pandemic The wide array of legal and policy responses to the COVID-19 pandemic have significant implications regarding the functioning of countries and their respective societies. This book addresses the impact of international legislative and policy responses to the COVID-19 pandemic in a range of countries. To aid the reader in understanding country-specific developments, each chapter focuses on a specific country and addresses the legal frameworks and policy approaches used to support measures to prevent transmission and otherwise reduce the impact of the virus on society and the economy. Sample topics discussed in the work include: The effect certain policies may have on civil liberties, such as due process, and the right to privacy in specific countries The provision of public goods in the face of the paTable of ContentsNotes on Contributors xiii Foreword xv Preface xix Section 1 Countries with a Focus on the Rule of Law and Legal Protections of Civil Liberties 1 1 The Netherlands: Dutch COVID-19 Policy Viewed from a Fundamental Rights Perspective 3Adriaan J. Wierenga and Jorrit Westerhof 1.1 Introduction 3 1.2 Disaster Management in the Netherlands 4 1.2.1 Functional and General Chain of Command 4 1.2.2 The COVID-19 Crisis 5 1.3 The Public Health Act 2008 (Functional Chain of Command) 5 1.3.1 National Crisis Structure 6 1.3.2 Measures 7 1.4 Municipal Emergency Powers (General Chain of Command) 8 1.4.1 Areas of Tension 8 1.4.2 Debatable Limitations of Fundamental Rights 9 1.4.3 Democratic Control and Administrative Supervision 10 1.5 Interim COVID-19 Measures Act (Addition to the Functional Chain of Command) 11 1.5.1 Improvements and Shortcomings 12 1.5.2 Legitimate Limitation of Fundamental Rights 12 1.5.3 Stricter Democratic Control 13 1.6 National Emergency Law 14 1.6.1 Separate Implementation 15 1.6.2 Criticism 16 1.6.3 The Curfew Case 17 1.7 Conclusion 18 References 19 2 Emergencies, Executive Power, and Ireland’s Response to the Covid-19 Pandemic 23Alan Greene 2.1 Introduction 23 2.2 Ireland’s Constitutional Emergency Framework 24 2.2.1 International Human Rights Law 26 2.3 Ireland’s Pandemic Response and Constitutional Constraints 27 2.3.1 Pandemic Rent Controls and Constitutional Constraints 28 2.3.2 Executive Supremacy and the COVID-19 Pandemic 29 2.4 Ireland’s Pandemic Response and Human Rights 31 2.4.1 The Pandemic and the Right to Liberty 31 2.4.1.1 Mandatory Hotel Quarantine 32 2.4.2 Quarantine and Detention at Home 34 2.5 Data Protection, Surveillance, and Discrimination Issues 36 2.5.1 Vaccination and Vaccine Passports 37 2.6 COVID-19 and the Rule of Law in Ireland 38 2.7 Conclusions 39 3 COVID-19: Legal Lessons Learned in Switzerland 41Felix Uhlmann 3.1 Introduction 41 3.2 Legal Framework 41 3.2.1 Legal Framework before COVID-19 (Swiss Epidemics Act) 41 3.2.1.1 Scope and Goals 41 3.2.1.2 Normal, Particular, and Extraordinary Situations 42 3.2.1.3 Measures 44 3.2.2 Legal Framework Under COVID-19 45 3.2.2.1 First and SecondWave 45 3.2.2.2 Financial Aid 47 3.2.2.3 The Federal Council and Other Actors 48 3.3 Contact Tracing App 48 3.4 Fundamental Rights (Civil Liberties) 50 3.4.1 Restrictions on Daily Life 50 3.4.2 Vaccinations 52 3.5 Assessment 53 References 54 4 Not Dead Yet: Protest, Process, and Germany’s Constitutional Democracy Amid the Coronavirus Response 59Carolyn Halladay 4.1 The FirstWave: So Far, So Good 60 4.2 Proportionality and its Discontents 65 4.3 Summer in the City 67 4.4 Is it an Emergency Yet? 71 4.5 Second Guessing the SecondWave 75 4.6 Happily Ever After? 77 5 The United Kingdom Legislative Response to Coronavirus: Shotgun or Machine Gun 79Ronan Cormacain and Duncan Fairgrieve 5.1 Introduction 79 5.2 Reliance Upon Law 79 5.3 Nature of the Legal Framework 80 5.3.1 Machine Gun Legislative Response 80 5.3.2 Devolution and the Legislative Response 80 5.3.3 Overview of the Legislative Framework 81 5.3.4 Pre-existing Laws or New Laws 84 5.3.5 Use of Emergency/Urgency Powers and Procedures or Use of Regular Powers and Procedures 84 5.3.6 Sunset Clauses/Expiry Dates 86 5.4 Substance of the Legal Response 86 5.4.1 Restrictions on Individual Liberties 86 5.4.2 Travel Restrictions 87 5.4.3 Vaccination Policy 87 5.4.4 Track and Trace 90 5.4.5 Support Measures – Furlough Payments, no Evictions 90 5.5 Problems/Analysis of the Legal Response 91 5.5.1 Reliance upon Emergency Procedures and Processes to Make Law in a Rush 91 5.5.2 Lack of Effective Parliamentary Scrutiny 92 5.5.3 Conflation of Law with Guidance 93 5.5.4 Inaccessible and Unintelligible Legislation 94 5.5.5 Risk of Creep of Emergency Practices into Normal Lawmaking 95 5.5.6 Compliance with the Rules by Those in Power 96 5.6 Conclusion 96 Section 2 Countries making Extensive use of Emergency Laws and Securitization 99 6 The State of Exception and its Effects on Civil Liberties in Italy During the COVID-19 Crisis 101Anna Malandrino, Margherita Paola Poto, and Elena Demichelis 6.1 Introduction 101 6.2 Defining the Elements of States of Exception (SoE) 103 6.2.1 States of Exception in the General Context 103 6.2.2 Italy 103 6.3 States of Exception During the Pandemic: Declaration, Implementation, and Effects 108 6.3.1 Establishing and Implementing the States of Exception 108 6.3.2 The Potential Effects of States of Exception on Civil Liberties 109 6.4 States of Exception and Containment Measures during the COVID-19 Pandemic in Italy: Regulatory Aspects 110 6.5 States of Exception and Containment Measures During the COVID-19 Pandemic in Italy: Implementation 112 6.6 The Effects of States of Exception Measures on Civil Liberties 113 6.7 Conclusions 116 References 116 7 Praise the Alarm: Spain’s Coronavirus Approach 121Carolyn Halladay, Florina C. Matei, and Andres de Castro 7.1 Quien aprisa juzgó, despacio se arrepintió: The Early Days of COVID and the Spanish Response 123 7.2 Culpa no tiene, quien hace lo que debe: The FirstWave and the First Lockdown 125 7.3 Cada uno quiere justiciar, mas no por su casa: The SecondWave and the Second Lockdown 130 7.4 Con necesidad, no hay ley? States of Emergency in Spain and Beyond 133 7.5 Hasta que pruebes, no absuelvas ni condenes: COVID and the Law Amid Spanish Tensions 137 7.6 El fin veremos; hasta entonces no hablemos: Conclusion 139 8 Pandemic Pangs and Fangs: Romania’s Public Safety and Civil Liberties in the COVID-19 Era 141Florina C. Matei 8.1 Legal Framework and Policy Approaches Vis-À-Vis Quarantine, Isolation, and Other Social Distancing Measures 141 8.2 Quarantine, Isolation, and Other Social Distancing Measures During the Covid-19 Pandemic 144 8.2.1 From a State of Emergency amidst a Political Crisis… 144 8.2.2 …To a State of Alert: Anachronistic Legislation Meets Ebbing and Flowing Restrictions 150 8.2.2.1 Vaccination Campaign: Needles for Fangs 153 8.2.3 Transparency During the Pandemic: Between Thought Police, Strategic “Mis” Communications, and Conspiracy Theories 154 8.2.3.1 Civil Society: A Tamed yet Clamorous Cerberus? 157 8.2.4 A “Plagued” Executive–Legislative–Judiciary Trifecta 159 8.3 Conclusion: Civil Liberties and Freedoms 161 9 Policymaking and Liberty Restrictions in the Covid-19 Crisis, the Case of France 165Angelique Palle, Lisa Carayon, François Delerue, Florian Opillard, and Christelle Chidiac Disclaimer 165 9.1 Introduction 165 9.2 Policymaking and Liberty Restrictions in France During Covid-19 Crisis, Research Questions and Methodology 166 9.3 Regulation and Policymaking in France During Covid-19, Context and Background 167 9.4 “State of Emergency Related to the Sanitary Situation/Etat d’Urgence Sanitaire”: The Recourse to an Exceptional Legal Framework 169 9.5 The Involvement of the Armed Forces in France in the Covid-19 Crisis Management, Between Political Display and Response to the Crisis 170 9.6 Perception by the French Population of the Missions Performed by the Armed Forces and of the Nature of the Covid-19 Crisis 172 9.7 Analyzing Local and Regional Measures of Civil Liberties’s Restrictions in the Context of the “State of Emergency Related to the Sanitary Situation” (état d’urgence sanitaire), the Case of the Freedom of Movement throughout the First to the Second Confinement 173 9.8 Legitimizing Civil Liberties Restrictions and Shaping the Governance of Policymaking, Comparison of the Two Cities of Rennes and Nice 175 9.9 Conclusion 179 References 179 Section 3 Countries Focused on Population Monitoring and Restrictions 181 10 Policy Measures, Information Technology, and People’s Collective Behavior in Taiwan’s COVID-19 Response 183Cheryl Lin, Pikuei Tu, Wendy E. Braund, Jewel Mullen, and Georges C. Benjamin 10.1 Introduction 183 10.2 A Snapshot of Taiwan 184 10.2.1 The Legal Framework Pertaining to Pandemic Response 184 10.2.1.1 Epidemic Control and Public Health Emergency 184 10.2.1.2 Personal Information 186 10.3 The Ominous Beginning of the Pandemic 186 10.3.1 Swift Responses Early On 187 10.4 Blocking Infection Importation and Local Transmission 188 10.4.1 Tightened Border Control 188 10.4.2 Rigorous Contact Tracing 189 10.4.2.1 Augmentation with Information Technology (IT) 189 10.4.3 Enforcing Quarantine – Operations and Mechanism 190 10.4.3.1 Provisions, Compensation, and Penalties During Quarantine 190 10.5 Active Participatory Role of the Public – Awareness and Preventive Behavior 192 10.5.1 Common Use of Masks and Response to Shortage 192 10.5.2 Promoting and Self-Adhering to Social Distancing 192 10.6 Healthcare System and Capacity 193 10.6.1 National Health Insurance (NHI) and Data Integration 193 10.6.2 Infectious Disease Control Medical Network 194 10.6.3 Assuring Care and Support for the Providers 195 10.7 The Heights of Cases, Anxiety, and Dilemmas 195 10.7.1 The Surge of Spring/Summer 2021 196 10.7.2 Amended Policies and Reflections of the Surge 197 10.8 Vaccine Supply, Hesitancy, and Distribution 198 10.8.1 Slow Delivery and Shortage of Supply 198 10.8.2 Vaccine Hesitancy and Demand 199 10.8.3 Vaccine Prioritization and Administration 200 10.9 Reflections and Conclusions 200 References 201 11 The Legislative and Political Responses of Viet Nam to the Covid-19 Pandemic: The Balancing of Public Health and Collective Civil Liberties 209Nguyen T. Trung and Nguyen Q. Duong Disclaimer 209 11.1 Introduction 209 11.2 Background: The FourWaves of Covid-19 in Viet Nam 211 11.2.1 The FirstWave (23 January–19 April 2020) 211 11.2.2 The SecondWave (25 July–2 September 2020) 212 11.2.3 The ThirdWave (28 January–13 March 2021) 213 11.2.4 The FourthWave (27 April–15 July 2021) 214 11.3 The Legislative Framework in Combating Infectious Disease 215 11.3.1 Legislative and Administrative Documents in Vietnam 215 11.3.2 The Constitution 215 11.3.3 The 2007 Law on Prevention and Control of Infectious Diseases 216 11.3.3.1 Prevention Measures 217 11.3.3.2 Combating Measures 217 11.3.3.3 Prohibited Activities and Fines for Failures to Implement Prevention and Combating Measures 218 11.3.4 The Criminal Code 219 11.3.5 Three Directives of the Prime Minister 220 11.4 The Policy Responses of the Vietnamese Government During the Pandemic 221 11.4.1 The Contact Tracing System 222 11.4.2 Quarantine Regulation 223 11.4.3 Social Distancing Measures 224 11.5 The Paradigm Shift in the Legal and Political Responses and the Balancing of Public Health and Civil Liberties 224 11.5.1 The Paradigm Shift in the Legal and Political Responses 225 11.5.2 The Balancing of Public Health and Civil Liberties 226 11.6 Conclusion 228 References 230 12 Singapore United 235Jacinta I-Pei Chen, Sharon H.X. Tan, Peak Sen Chua, Jeremy Lim, and Jason Chin-Huat Yap 12.1 Governing Philosophy and Laws 235 12.2 Early Response to Circuit Breaker (February–May 2020) 237 12.2.1 Enforcement Approach 242 12.2.2 Financial and Other Supportive Resources 243 12.2.3 Religion, Marriage, and Family Life 244 12.2.4 Communications 245 12.3 Relaxation of Measures (June 2020–April 2021) 246 12.3.1 Prioritizing Sectors 251 12.3.2 Strengthening Outbreak Control Capabilities 251 12.3.3 General Elections 2020 253 12.4 Heightened Alert (May 2021–June 2021) 254 12.5 Leveraging Technology 261 12.5.1 Data Privacy, Security, and Governance 263 12.5.2 What Next? 264 12.6 MigrantWorker Dormitories 264 12.6.1 The Regulatory Regime 265 12.6.2 The Dormitory Outbreaks 265 12.6.3 Reflections 266 12.7 Discussion 271 12.8 Conclusion 272 Acknowledgements 273 References 273 Section 4 Countries Focused on Fostering Popular Trust in Government, Emphasizing Social Welfare, and Limiting Sanctions and Restrictions 301 13 Sweden and Covid-19: A (Mainly) Recommendary Approach 303Iain Cameron and Anna Jonsson Cornell 13.1 Introduction 303 13.2 Setting the Stage – The Initial Swedish Response to the Pandemic 303 13.3 The Constitutional Context 305 13.4 The Legislative Procedure, Delegation of Powers, and Rights Protection 308 13.5 The Public Health Agency and the Act on Protection Against Contagious Diseases 309 13.6 Legal Measures Taken to Counter the Spread of Covid-19 311 13.7 Vaccination and Exit Strategies 312 13.8 Putting the Swedish Soft Power Strategy in Context 313 13.9 Evaluating the Swedish Measures from a Rule of Law Perspective 315 13.10 Concluding Remarks 319 14 Administrative Guidance in Coronavirus Special Measures Act in 2021 in Japan 323Yuichiro Tsuji 14.1 The 2020 CSMA 323 14.1.1 2021 CSMA and Administrative Guidance 323 14.1.2 How CSMA was Amended 325 14.1.3 How CSMA was Amended, and Why 326 14.1.4 Legalization of the Self-restraint Order 326 14.1.5 Sanctions, not Penal but Administrative 327 14.1.6 Revision of the Infectious Diseases Act 328 14.2 Administrative Guidance and COVID-19 in 2021 329 14.2.1 Traditional Theory in Japanese Administrative Law 330 14.2.2 Legal Control of Administrative Guidance 330 14.2.3 Art. 33 of APA When a Citizen does not Follow Administrative Guidance 331 14.2.4 Public Announcement 332 14.2.5 Public Announcement in TMG 332 14.2.6 Merits and Demerits of Administrative Guidance 333 14.2.7 How to Impose Administrative Fine Procedural Requirement 334 14.2.8 APA Ordinance and TMG 334 14.3 Conclusion 335 References 336 15 Canada’s Fight Against COVID-19: Constitutionalism, Laws, and the Global Pandemic 339Iffath U. Syed 15.1 Non-Pharmaceutical Intervention (NPI) Measures 340 15.2 COVID-19 Special Acts for Relief and Compensatory Measures 341 15.3 Long-Term Care Crisis 346 15.4 Research and Vaccine Development Initiatives 347 15.5 Other Policies and Governmental Actions to Dampen the Pandemic 347 15.6 New Year, But Pandemic Looms 350 15.7 Summary, Limitations, and Concluding Remarks 351 References 351 16 Coronavirus and the Social State: Austria in the Pandemic 359Donald Abenheim and Carolyn Halladay 16.1 The Impfpflicht 361 16.2 The Freedom Party’s Liberties 363 16.3 A Bundle of Measures 364 16.4 A Decade or More of Crises 367 16.5 The Sozialstaat Strikes Back 371 16.6 Protest, Rhetoric, and the Law 373 16.7 Conclusion: Community, Communicability, and the Constitution 376 Afterword 379 Index 381

Read more less

Book SynopsisHerbal Drug for the Management of Infectious Diseases The book is a comprehensive compilation of herbal drug applications for the treatment and management of infectious diseases and addresses issues related to development, challenges, and future prospects associated with the use of herbal medicine. The use of herbal medicines has evolved in various cultures around the world over many millennia. In many developing Asian and African countries, the use of herbal medicines, as supplied by traditional medicinal practitioners, has always been popular. In the last two to three decades, many people in developed countries have begun to turn to alternative or complementary therapies, including the use of herbal medicines, nutraceuticals, functional foods, and other supplements. This resurgence in interest in plant-derived medicines is partly due to the growing dissatisfaction with allopathic medicines, as well as the perception that plant-derived mediTable of ContentsPreface xvii 1 Essential Oils as Potent Antimicrobial Agents 1Rakesh K. Sindhu, Prabhjot Kaur, Parneet Kaur, Sumitra Singh and Simona Cavalu 1.1 Introduction 2 1.2 Essential Oils 3 1.3 Chemical Composition of Essential Oils 5 1.4 Mechanism of Action of Essential Oils as Antimicrobials 11 1.5 Factors Affecting Antimicrobial Activity of Essential Oil 13 1.6 Essential Oils as Combination Therapy 13 1.7 Evaluation of Antimicrobial Efficacy of Essential Oils 14 1.8 Conclusion and Future Perspectives 16 2 Herbal Antibiotics for Treating Drug-Resistant Bacteria 23Haixia Chen and Shuqin Li 2.1 Introduction 24 2.2 Resistance Mechanism of Strains 25 2.3 The Classification of Herbal Secondary Metabolites for Drug Resistance 28 2.4 Mechanism 41 2.5 Conclusion and Perspectives 44 3 Phytopharmaceuticals for the Management of Fungal Infections 55Kampanart Huanbutta and Tanikan Sangnim 3.1 Introduction 55 3.2 Nature of Fungi and Classification of Fungal Disease 56 3.3 Epidemiology of Fungal Infection 58 3.4 Limitations of Modern Medicines 60 3.5 Medicinal Plants With Antifungal Activities 61 3.6 Phytopharmaceuticals With Antifungal Activities 63 3.7 Activity and Mechanism of Action of Antifungal Drugs and Phytopharmaceuticals 68 3.8 Conclusion and Future Prospect of Phytopharmaceuticals for the Management of Fungal Infections 72 4 Herbal Bioactives for the Management of Influenza Viral Infection 85Shaveta Bhardwaj, Jobanpreet Kaur, Atinderpal Kaur, Satvinder Kaur, Anu Jindal and Inderbir Singh 4.1 Introduction 86 4.2 Various Herbal Bioactives With Anti-Influenza Property 87 4.3 Mechanism of an Anti-Influenza Effect 91 4.4 Conclusion 93 5 Herbal Bioactives for Treating Respiratory Infections 101Chandrakantsing V. Pardeshi, Sagar R. Pardeshi, Jitendra B. Naik, Atul A. Shirkhedkar and Sanjay J. Surana 5.1 Introduction 101 5.2 Overview of Respiratory Tract Infections 103 5.3 Herbal Bioactives for the Management of RTIs 108 5.4 Bioactives and Their Derivatives Against Novel Coronavirus Disease 112 5.5 Emerging Drug Delivery Strategies for Biomedicines in the Management of RTIs 113 5.6 Clinical Status: Opportunities and Challenges 120 5.7 Patent Perspectives 120 5.8 Future Perspectives 122 5.9 Conclusion 122 6 Herbal Bioactives for the Treatment of Gastrointestinal Tract Disorders 133Manish Kumar, Inderjeet Verma, Rakesh Kumar Sindhu and Rishabh Srivastava 6.1 Introduction 134 6.2 Classification of GIT Disorders 134 6.3 The Science of Herbal Medicine 135 6.4 Need of Herbal Medicine 143 6.5 Indirect Adverse Effects of Herbal Therapy 144 6.6 Herbal Bioactive-Based Formulation 144 6.7 Recent Patents for Herbal Drug Delivery Systems 148 6.8 Future Perspective 148 6.9 Conclusion 148 7 Herbal Drugs for the Treatment of Ocular Infections 157A. A. Shirkhedkar, Mukesh S. Patil, A. S. Patil and Inderbir Singh 7.1 Introduction 158 7.2 Eye Essential Anatomy and Physiology 159 7.3 Preparation and Method of Use 161 7.4 Modern Investigations and Findings 163 7.5 Patents Recently Issued on Herbal Formulations 170 7.6 Conclusion 171 8 Phytopharmaceuticals for Treating Sexually Transmitted Diseases 179Kenneth Chinedu Ugoeze 8.1 Introduction 180 8.2 Disease 180 8.3 Infectious Diseases 181 8.4 Types of Infectious Diseases 181 8.5 Treatment of Sexually Transmitted Diseases 190 8.6 Phytochemicals 194 8.7 Phytopharmaceuticals 195 8.8 Future View of Phytopharmaceuticals: The Need for Patenting 225 8.9 Summary 226 8.10 Conclusion 229 9 Herbal Bioactives for Treating Infectious Skin Diseases 263Darshan R. Telange, Saurabh B. Ganorkar and Atul A. Shirkhedkar 9.1 History of Treating Skin Diseases With Herbs 264 9.2 Herbal Bioactives for Treating Infectious Skin Diseases 9.3 Herbs of Choice for Skin Infections 271 9.4 Herbal Bioactive--Based Formulations for Skin Infections 280 9.5 Patent Perspective 282 9.6 Futuristic View 283 9.7 Conclusion 284 10 Plant-Based Vaccines: Challenges and Opportunities 291Navgeet Kaur, Anju Goyal and Rakesh K. Sindhu 10.1 Introduction 292 10.2 Production Process of Plant-Based Vaccines 293 10.3 Current Scenario of the Vaccines 297 10.4 Challenges 299 10.5 Conclusion and Future Prospects 300 11 Herbal Medicines for HIV Infection and AIDS 307Thongtham Suksawat and Pharkphoom Panichayupakaranant 11.1 Introduction 308 11.2 Pathophysiology of HIV Infections 309 11.3 Current Treatments for HIV/AIDS 310 11.4 Targeting for Novel Drug Therapy Against HIV/AIDS 311 11.5 Herbal Extract and Phytochemicals with Anti-HIV Effects 312 11.6 Patents of Herbal and Phytochemical Products for Anti--HIV-1 Infections 330 11.7 Conclusions 332 12 Anthelmintic Potential of Herbal Drugs 341Kalpana Nagpal, Pravin Pawar, Ritu Rathi, Nishant Gaur and Inderbir Singh 12.1 Introduction 342 12.2 Drugs Used as Anthelmintics 342 12.3 Active Principles Derived From Medicinal Plants as Anthelmintic Compounds 349 12.4 Conclusion 352 13 Herbal Drugs for the Management and Treatment of Herpes Simplex Infections 359Wiwit Suttithumsatid and Pharkphoom Panichayupakaranant 13.1 Introduction 360 13.2 Pathophysiology of HSV Infections 360 13.3 Current Treatments for HSV Infection 361 13.4 Targeting for Novel Drug Therapy Against Herpes Simplex Infection 363 13.5 Herbal Extracts and Phytochemicals With Anti-HSV Activity 363 13.6 Recommended Herbal Extracts Used for Herpes Simplex Infection and Futuristic View 381 13.7 Patents on Herbal Medicine for Anti-Herpes Simplex Infections 381 13.8 Conclusions 383 14 Herbs and Plants Used for the Management and Treatment of Hepatitis Infections 389Omonike O. Ogbole, Temitayo A. Ajayi and Oluwatoyin A. Odeku 14.1 Introduction 390 14.2 Hepatitis 391 14.3 Herbal Medicine and Control of Viral Infection 397 14.4 Major Classes of Medicinal Plants Having Activity Against Hepatitis Virus 398 14.5 The Common Classes of Bioactive Compounds with Anti-Hepatitis Virus Activities 406 15 Herbal Bioactives for Treating Urinary Tract Infections 427Kashish Wilson, Manish Kumar, Prerna Sharma, Harkiran Nehra and Inderjeet Verma 15.1 Introduction 428 15.2 Discussion on Medicinal Plants 431 15.3 Causes of UTI 431 15.4 Symptoms of a UTI 432 15.5 Management 432 15.6 Herbs Employed for Therapy of Urinary Tract Infection 433 15.7 Causative Agents in Infection of Urinary Tract 436 15.8 Mechanism of Herbs 438 15.9 Future Prospective 438 15.10 Conclusion 439 16 Herbs Used in Parasitic Infection--Malaria 443M.G. Kalaskar, B. Duraiswami, S.J. Surana and A.A. Shirkhedkar 16.1 Introduction 444 16.2 Parasitic Infections 445 16.3 Antiparasitic Medicinal Plants and Their Mode of Action 450 16.4 Antimalarial Herb 452 References 509 Index 519

Read more less

Book SynopsisTable of ContentsAcknowledgments ix Introduction xChapter 1 The $1000 Pill: the Fiscal Consequences of Curing Hepatitis C 1 Chapter 2 Enter the Payers: Fda Approval Does Not Guarantee Commercial Success 10 Chapter 3 Pandemic: mRNA Vaccines And The Race For A Cure 19 Chapter 4 Federal Investment in R&d: Why the Government Does Not Deserve a Piece of Biopharma’s Profits? 34 Chapter 5 Insulin: the True Cost of a 100- Year- Old Drug 44 Chapter 6 The Costly Alzheimer’s Disease Drug: a Questionable Breakthrough 50 Chapter 7 Gene Therapy: How Much Is a Life Worth? 60 Chapter 8 Proving the Value of Expensive Drugs: Should We Pay For Drugs Whose Ultimate Value Is Unknown? 70 Chapter 9 Generic Drugs: Built- in Cost Controls 74 Chapter 10 About Those Soaring Pharma Profits: Are They Driving Healthcare Costs? 80 Chapter 11 Schemes to Lower Drug Prices: the Impact of Reduced Resources on R&d 84 Final Thoughts 96 Index 98

Read more less

Book SynopsisPharmacological Studies in Natural Oral Care Edited by a natural product scientist, clinician, pharmacologist and a dental surgeon, the book helps oral care specialists to implement safe and effective natural medicine therapies to complement current practice guidelines. With oral care specialists focusing their attention on the interdisciplinary connections between oral health, heart health, gastrointestinal health, etc., and with increasing antibiotic resistance and stronger antibiotics now reserved for serious active infection, the importance of herbal antibiotics is increasing exponentially. This book helps to implement safe and effective natural medicine therapies to complement the current practice guidelines. Pharmacological Studies in Natural Oral Care is a comprehensive compilation and explores all the measures to utilize the natural oral care obtained from plants, animals, and mineral drugs for dental care. Herbal extracts are used in dentistry for reducing inflammation, as antTable of ContentsPreface xxv Part I: Phytopharmaceuticals in Various Diseases 1 1 Ayurvedic Approaches to Oral Health and Hygiene: A Review 3Manindra Mohan Shrivastava, Prashant Kr. Gupta, Kamal Shah, Durgesh Nandini Chauhan and Nagendra Singh Chauhan 2 Emerging Role of Medicinal Plants in the Prevention of Oral Cavity Disorders 33Navneet Kishore and Bhanu Pratap Singh 3 Natural Oral Care and Herbal Products for Oral Diseases and Oral Hygiene Maintenance 47Goma Kathayat, Diane Isabel Selvido, Hans Erling Skallevold, Maan Bahadur Rokaya, Bishwa Prakash Bhattarai, Anand Marya and Dinesh Rokaya 4 Complementary and Alternative Medicine: Gains and Drawbacks with Special Reference to Oral Healthcare 61Ezi Abigail Akaji 5 Nutraceutical Agents on Oral and Periodontal Health and Disease 83Gaetano Isola, Alessandro Polizzi and Simona Santonocito 6 Role of Herbal Products as Denture Disinfectants and Cleansers 103Jacob Mathew Philip, Helen Mary Abraham, Tamizhesai, M. Navin Bharathy, C.J. Venkatakrishnan, Saranya Varadarajan, Raghunathan Jagannathan and Thodur Madapusi Balaji 7 Use of Natural Oral Care Products in Orthodontics 125Anand Marya, Mohmed Isaqali Karobari, Pravin Kumar Shah and Dinesh Rokaya 8 Herbs and Their Applications as Root Canal Medicaments 149S. Balagopal, Vandana James, Nagarajan Geethapriya, Shekar Shobana, Saranya Varadarajan, Raghunathan Jagannathan and Thodur Madapusi Balaji 9 Herb-Derived Phytochemicals for Dental Implant Applications 167Saranya Varadarajan, Narasimman Muthusamy, Nithiyarajan Nambirajan, Rathinavel Pandian Manickavel, C.J. Venkatakrishnan, Jimson Samson, Raghunathan Jagannathan, Thodur Madapusi Balaji, S. Lakshmi Priya and Swaminathan Rajendran 10 Natural Compounds in the Treatment of Oral Submucous Fibrosis 183Urmi Ghone, Gargi Sarode and Sachin Sarode 11 The Effects of Natural Products on Mouth Sores 197Marzie Boskabady, Sepide Behrouz, Mahla Mohammadi and Mohammad Hossein Boskabady 12 Natural Products to Cure Bad Breath 217Khalid Mohammed Khan, Shehryar Hameed and Shahbaz Shamim 13 Herbal Formulations as Denture Cleansers 253Amar Bhochhibhoya, Sahara Shrestha, Rejina Shrestha and Manjeev Guragain 14 Natural Oral Care Therapy for Peri-Implant Diseases 269Bharat Mirchandani, Hans Erling Skallevold, Artak Heboyan, Diane Isabel Selvido, Viritpon Srimaneepong, Pasutha Thunyakitpisa and Dinesh Rokaya 15 Natural Compounds in the Treatment of Recurrent Aphthous Stomatitis 285Gargi Sarode, Madhura Pawar, Vivek Pawar and Sachin Sarode 16 Alveolar Bone Protective Effects of Natural Products 299Diane Isabel Selvido, Hans Erling Skallevold, Bishwa Prakash Bhattarai, Rajesh Dashaputra, Azeem UI Yaqin Syed and Dinesh Rokaya 17 Natural Oral Care Products for the Treatment of Stomatitis 311Vivekanand Kattimani, Gnana Sarita Kumari Panga, Swetha Gnanavel, Deepeka Saravanan and Nagalaxmi Hymavathi Chintalapati Part II: Plants and Phytoconstituents Used in Natural Oral Care 357 18 Cranberry and Oral Health 359Kamal Shigli, Sushma S. Nayak, U. B. Bolmal and Kamal Shah 19 Mangroves: Potent Botanicals as Therapeutics for Oral Ailments 391Merry Kashyap, Akshar Radhakrishnan, Priyanka Singh, Amrita Sinharay, Kavyasree Marabanahalli Yogendraiah and Santosh Anand 20 Tea Tree Oil on Oral Health -- A Systematic Review 403Kalyana Chakravarthy Pentapati and Chenna Deepika 21 Oregano Oil and Grape Seed Oil -- A Potent Displacer of Commercially Available Denture Cleansers 425Shetty Prajna P., Chowdhary Ramesh, Shetty Pooja P. and Volety Supraja 22 Punica granatum (Pomegranate): A Potential Herbal Medicine in Treating Periodontal Disease in the Modern World of Dentistry 435Sumanth Gunupati, Sukrutha Biradavolu, Priyanka Nitin and Thummala Kalyani 23 Potential Effects of Schinus terebinthifolia Raddi (Anacardiaceae) for the Treatment of Oral Conditions 453Ana Carolina Rivas, Nathalya Maria Vilela Moura and Mario Taba Jr. 24 Melatonin: A Naturally Derived Molecule as a Protector of Oral Health 467Thodur Madapusi Balaji, Saranya Varadarajan, C.J. Venkatakrishnan, Raghunathan Jagannathan, Bhuvaneswari Birla Bose, Juala Catherine, Vignesh Vikram, T. Parthasarathi, S. Lakshmi Priya and Swaminathan Rajendran 25 Myrrha and Oral Health 485Randa A. Alfotawi 26 Syzygium aromaticum -- Role in Oral Health and Dental Care 499Vahid Reza Askari, Zohre Najafi and Vafa Baradaran Rahimi 27 Acemannan: A Promising Natural Polysaccharide in Dentistry 519Hans Erling Skallevold, Dinesh Rokaya and Pasutha Thunyakitpisal 28 Piper betel Linn. (Betel Leaf) and Its Beneficial Effects in Orodental Ailments: A Memoir 539Aditya Shetty, Princy Louis Palatty, Bharathi Shetty, Sembagalakshmi Thirunarayanan, Priyanka Latha Senthilkumar, Sharake Meera, Suresh Rao, Shamprasad Varija Raghu and Manjeshwar Shrinath Baliga 29 Aloe Vera and Oral Health: A Systematic Review 553Kalyana Chakravarthy Pentapati, Hanan Siddiq and Abhinav T.N. 30 Cinnamomum zeylanicum -- A Review for Its Role in Oral Health and Dental Care 577Vahid Reza Askari, Zohre Najafi and Vafa Baradaran Rahimi 31 Babool (Acacia nilotica) and Oral Health 597Anupam Jaiswal, Megha Verma, Seema Kohli, Durgesh Nandini Chauhan, Kamal Shah and Nagendra Singh Chauhan 32 Applications of Andrographis paniculata and Its Constituents for Management of Oral Diseases 607Ambili R., Nisha K.J., Biji Brigit K. and Rema J. Part III: Advancement in Natural Product Oral Care 629 33 In Silico Approach with Phytochemical Analysis and Its Role in Oral Potentially Malignant Disorders (OPMD) and Oral Cancer 631Vaibhav Sunil Ladke, Gitanjali Javir and Gauri M. Kumbhar 34 Anticancer Activities of Trigonella foenum-graecum L. and Trigonelline on an Oral Squamous Cell Carcinoma Cell Line 641Saranya Varadarajan, Thodur Madapusi Balaji, Malathi Narasimhan, Durai Pandian Chamundeeswari Meenakshi and Dhanapal Sakthisekaran 35 Evaluation of The Anti-Inflammatory Action of Andiroba Oil -- Carapa guianensis aubl (Meliceae) in Oral Mucositis 651Fabricio Mesquita Tuji, Priscilla Bittencourt de Almeida Figueiredo, Gabriel Henrique Soares Cavalcante and Rommel Mario Rodriguez Burbano 36 Trends of Clinical Studies with Xylitol or Propolis Toothpastes 669Mariana Leonel Martins, Natália Magno Von Helde, Yuri Wanderley Cavalcanti, Lucianne Cople Maia and Andréa Fonseca-Gonçalves 37 Use of Polyols in Dentistry: Effects on Tooth Mineral Dynamics and Oral Biofilms 689Igor Zen, Tamires Passadori Martins, Caio Sampaio, Alberto Carlos Botazzo Delbem, Douglas Roberto Monteiro and Juliano Pelim Pessan 38 Therapeutic Activity of Salvia officinalis L. Hydro-Ethanolic Extract from Aerial Parts on Dental Disease 703Maryam Eidi and Reza Ghahramani 39 Effect of Black Pomegranate Hydro-Ethanolic Extract from Peel in Diabetic Male Rats with Candida albicans Oral Mucosa Infection 713Maryam Eidi and Reza Ghahramani 40 In Vitro and In Vivo Efficacy of Phytoactive-Based Oral Care Regimens in the Prophylaxis of Oral Biofilm and Augmentation of Oral Hygiene 723Arumugam Priya, Nagaiah Hari Prasath, Nambiraman Malligarjunan and Shunmugiah Karutha Pandian 41 Natural Oral Care Approach and Application in COVID-19 Management 775Beuy Joob and Viroj Wiwanitkit 42 Fabricated Plant-Based Nanoformulations: Therapeutics for Oral Health 793Santosh Anand and Prabhakar Mishra Index 807

Read more less

Book SynopsisBenefitting from phytochemicals in medicinal plants has lately gained increasingly more global relevance. The medicinal bioactivity might range from wound healing activity to anti-inflammatory and anti-viral effects. This work describes the challenging scientific process of systematic identification and taxonomy through molecular profiling and nanoparticle production from plant extracts until a final use for e.g. cancer or HIV treatment. From the table of contentsPART A: Biodiversity & Traditional Knowledge.__Habitats and Distribution.__Threats and Conservation.__Culture, tradition and indigenous practices.PART B: Phytochemical constituents – Molecules and Characterization Techniques.__Alkaloids & Flavonoids.__Tannin, Saponnin and Taxol.__Terpenoids, Steroids and Phenolic Compounds.__Essential oil and their constituents.__Characterization Techniques used for the analysis of phytochemical constituents.PART C: Medicinal Bioactivity.__Anti-cancerous and Anti HIV activity.__Anti-microbial, Anti-inflammatory and wound healing activity.__Anti-oxidant activity.__Anti-diabetic activity.__Anti-Corona virus and anti-viral activity.PART D: Nanotechnology.__Nano-materials synthesis from medicinal plant extract.__Characterization and activity of medicinal plant based nanoparticles.PART E: Pharmacology/Drug discovery.__Plant phytochemicals in drug discovery.__Extraction and production of drugs.__System pharmacology and drug discovery.

Read more less

Book SynopsisThe research on carbon dots is evolving and expanding very rapidly. A high-tech overview for academia and industry is needed to modernize carbon dots in biological applications. This book covers the use of carbon dots in biology, medicine, and pharmacy: synthesis, properties and applications, obstacles in exploiting these materials, and future research prospects. The reader is able to explore the wide scope of carbon dots in the global market.

Read more less

Book SynopsisWith the advancement in medicinal chemistry and material science, several highly specific, biocompatible and non-toxic therapeutic agents have been discovered and successfully applied for various clinical applications. Many of the conventional constraints of clinical therapies have been replaced and overcome by the multifaceted applications of material science and nanotechnology. Recently, material science-based therapeutic agents are the major global pharmaceutical market and are believed to mount exponentially shortly. Among the various therapeutic agents, hydrogels are one of the most widely applied materials used in the treatment of various diseases, and one of the most diverse materials that are used for multipurpose applications. Hydrogels were the first biomaterials used for Human being. Hydrogels are polymeric linkages, water-insoluble, however, sometimes established as a colloidal gel in water. Hydrogels are the superabsorbent materials because it can absorb more than 90% water, and hence regarded as natural living tissue. Mechanically strong hydrogels were synthesized by the advent of new synthetic strategies. Owing to the swollen properties, three-dimensional polymer network, and strong mechanical characteristics, these are widely used in catalysis, adsorption, drug delivery systems for proteins, contact lenses, wound dressings, wound healing, bone regeneration, tissue engineering, baby diapers, food rheology, and many others. Due to their diverse applications, hydrogels are considered one of the smartest materials in pharmaceutics, and are eco-friendly materials, cheap, and have good recyclability. They are used as therapeutic agents in different health sectors. As they are very sensitive to target, therefore it is considered favorite and preferred choice in biomedical sectors. Patients are psychologically scared of surgeries regarding huge expenses and failure. So researchers are working on hydrogels as alternative surgical replacement. In most cases, they have successfully achieved research on hydrogels in bones and tissues repairment. It might be hope of life for serious patients in future. The domain of this work will cover state of the art potentials and applications in various technological areas.

Read more less

Book SynopsisThe pharmaceutical industry is currently facing a significant innovation deficit, despite the potential offered by advances in genomics, high throughput screening, and combinatorial and asymmetric synthesis for drug discovery. The number of new molecules registered annually has actually decreased, contrary to expectations, and post-marketing failures of blockbuster drugs have become a major concern. On the other hand, there is a growing global trend towards the use of traditional medicine, including complementary and alternative therapies. Ethnopharmacology and traditional medicines have played a significant role in the past in the discovery of natural products, and there are two clear areas where ethnopharmacology can make a significant contribution to future drug research. First, as a discovery engine for new targets, leads, and second, the use of quality-assured and standardized traditional medicines. This book provides a historical perspective, future prospects, and the significance of ethnopharmacology in drug research, as well as important steps in botanical drug discovery and development, including bioprospecting, quality control, standardization, pharmaceutics, stability, pharmacokinetics, and bioavailability, with examples from ethnopharmacology and herbal medicine. The book also includes an excellent overview of Good Laboratory and Good Clinical Practices, as well as very useful summary steps for filing IND or NDA for botanical products. Additionally, the book provides the regulators perspective on validating claims and how ethnopharmacological or traditional medicines may require a different approach.

Read more less

Book SynopsisWhile biotechnological advances, genomics and high throughput screenings or combinatorial and asymmetric syntheses are opening new opportunities in drug discovery, the industry is facing serious innovation deficit. The total number of new molecules registered per year has dropped in contrast to expected increase. Post marketing failures of blockbuster drugs have become major concerns of industries. On the other side, globally there is a major shift to sue of traditional medicine involving complementary and alternative therapies. Ethnopharmacology and traditional medicines have contributed in past significantly in the process of natural product drug discovery. There are two clear tracks where ethnopharmacology has potential to contribute in future drug research. First, as a discovery engine to provide new targets, leads, and second, use of quality assured and standardized traditional medicines. In this scenario, it is important to understand the mechanisms of drug discovery and pharmaceutical development with a focus on herbal drugs and neutraceutical. This book provides historical perspective, future prospects and significance of ethnopharmacology in drug research. It also provides important steps in botanical drug discovery and development including bioprospecting, quality control, standardization, pharmaceutics, stability, pharmacokinetics, and bioavailability with examples from ethnopharmacology and herbal medicine. One of the important feature of this book is to give an excellent insight to Good Laboratory and Good Clinical Practices along with very useful summary steps involved in filing IND or NDA of botanical products. The book also gives Regulators' perspective of validating claims and how ethnopharmacological or traditional medicines need different approach.Table of ContentsSection I. Discovery: 1. Overview of medical and drug development. 2. TM/CAM and ethnopharmacology. 3. Natural product and drug discovery. 4. Innovation and drug discovery. 5. Bioprospecting and IPR. Section II. Development 6. Safety and regulatory issues. 7. Quality control and standardization. 8. Herbal pharmaceutics: stability and pharmacokinetics. 9. Preclinical and clinical evaluation. 10. Regulatory guidance to industry. 11. Validating of health claims and pharmacoepidemiology.Section III. Technology: 12. Biotechnology in herbal drug research. 13. Microarrays and high throughput screening. 14. Pharmacogenomics and ethnopharmacology. 15. Ethnoinformatics and AyuSoft. 16. Systems approaches and reverse pharmacology. 17. Future perspectives.

Read more less

Book SynopsisBURNT HUMAN REMAINS An all-encompassing reference and guide designed for professionals involved in the forensic analysis of burnt remains Burnt Human Remains: Recovery, Analysis and Interpretation presents an in-depth multidisciplinary approach to the detection, recovery, analysis, and identification of thermally altered remains. Bridging the gap between research and practice, this invaluable one-stop reference provides detailed coverage of analytical techniques in forensic medicine and pathology, forensic anthropology, forensic odontology, and forensic chemistry and forensic biology. Contributions from a panel of expert authors review the newest findings in forensics research and discuss their applicability to forensic case work. Opening with a historical overview of the discipline, the book covers the search and recovery aspects of burnt human remains, medico-legal investigations, determination of the post mortem interval of burnt remains, structuTable of ContentsAbout the Editors xiii List of Contributors xv Preface xxvii Series Preface xxix 1 History of the Study of Burnt Remains 1Douglas H. Ubelaker and Austin A. Shamlou 1.1 Early Developments Prior to 1980 1 1.2 Post-1980 Advanced Experimentation and Casework 3 1.3 The 1990s: New Methods and Case Applications 4 1.4 Summary and Conclusions 6 References 7 Part 1 Search and Recovery of Burnt Human Remains from the Fire Scene 2 Fire Environments and Characteristic Burn Patterns of Human Remains from Four Common Types of Fatal Fire Scenes 13Elayne Pope 2.1 Introduction 13 2.2 Experimental Research of Fire and Human Bodies 14 2.3 How the Human Body Burns 14 2.4 Variables of Fire Environments 17 2.5 Structure Fires 18 2.6 Burning Directly on the Floor 19 2.7 The Body on Furnishings: Couches and Chairs 19 2.8 The Body on Furnishings: Bed 21 2.9 Loss of the Floor 22 2.10 Collapse into a Lower Level 23 2.11 Vehicle Fires 24 2.12 Driver and Passenger Space 25 2.13 Rear Passenger Space with Bench Seats 26 2.14 Trunk Environment 26 2.15 Confined Space Fires 28 2.16 Outdoor Space Fires 29 2.17 Ignitable Liquids on Bodies 29 2.18 Burning Outdoor Debris Piles 30 2.19 Post-Fire Fragmentation of Burnt Bones 31 2.20 Suppression 32 2.21 Recovery and Transport from Fatal Fire Scenes 33 2.22 Conclusions 35 References 35 3 Recovery and Interpretation of Human Remains from Fatal Fire Scenes 37Alexandra R. Klales; Allison Nesbitt; Dennis C. Dirkmaat and Luis L. Cabo 3.1 Introduction 37 3.2 Summary of Fires in the USA 39 3.3 Statement of the Problem 39 3.4 Current Fatal Fire Victim Recovery Protocols 42 3.5 NIJ Protocols 43 3.6 Special Circumstances 51 3.7 Conclusions 55 References 55 4 Considerations to Maximize Recovery of Post-mortem Dental Information to Facilitate Identification of Severely Incinerated Human Remains 59John Berketa and Denice Higgins 4.1 Introduction 59 4.2 Identification 59 4.3 Documentation 60 4.4 Preparation 61 4.5 Prepacked Scene Equipment 61 4.6 Scene Arrival 63 4.7 Safety Issues 63 4.8 Overall Scene Evaluation 65 4.9 Considerations Regarding DNA Evidence 66 4.10 Considerations Regarding Dental Evidence 67 4.11 Moving the Victim 69 4.12 Conclusions 71 References 71 Part 2 Examination and Identification of Burnt Human Remains 5 Methods for Analyzing Burnt Human Remains 75Amanda N. Williams 5.1 Anthropological Methods for Classifying Burnt Remains 76 5.2 Medicolegal Classification Methods 78 5.3 Need for New Model within the Forensic Sciences 79 5.4 A New Classification System 80 5.5 Best Practices in Applying this New Model 83 5.6 Case Study #1 83 5.7 Case Study #2 86 5.8 Case Study #3 88 5.9 Case Study #4 90 5.10 Case Study #5 92 5.11 Broader Implications 95 5.12 Conclusions 95 Acknowledgments 96 References 96 6 Burnt Human Remains and Forensic Medicine 99Sarah Ellingham; Joe Adserias-Garriga and Peter Ellis 6.1 Fire Death Statistics 99 6.2 Statistics of Manner of Fire-Related Deaths 100 6.2.1 Prevalence of Self-Immolation 100 6.2.2 Prevalence of Criminal Immolation 101 6.3 Fire Damage to the Body 102 6.4 Classification of the Degree of Fire Damage 103 6.5 Medicolegal Determination of Cause of Death 105 6.6 Medicolegal Determination of Manner of Death 106 6.7 The Use of Post-Mortem Imaging for the Analysis of Burn Victims 108 6.8 Conclusion 110 Acknowledgments 110 References 110 7 Skeletal Alteration of Burnt Remains through Fire Exposure 113Joe Adserias-Garriga 7.1 Assessment of the Severity of the Thermal Damage in the Forensic Context 114 7.2 Soft Tissue Alterations by Fire Exposure 115 7.3 Bone Alteration by Fire Exposure 116 7.4 Teeth Alteration by Fire Exposure 120 7.5 Signature Changes in Skeletal Elements after Cremation 122 7.6 Conclusions 129 References 130 8 Challenges of Biological Profile Estimation from Burnt Remains 133Tim J.U. Thompson 8.1 Why Does Burning Affect Methods of Identification? 134 8.2 How Does the Context of Burning Impede the Creation of Biological Profiles? 135 8.3 Challenges of Biological Profile Estimation of Burnt Remains 137 8.3.1 Morphological Methods 137 8.3.2 Metric Methods 139 8.3.3 Other Approaches to Biological Profile Estimation 140 8.4 Conclusions 142 References 142 9 Victim Identification: The Role of Incinerated Dental Materials 147Peter J. Bush; Mary A. Bush and Raymond Miller 9.1 Introduction 147 9.2 Microstructural Changes in Teeth after Incineration 148 9.3 Structural Changes Due to Restorative Procedures 149 9.4 Case Reports 151 9.4.1 Case Report 1: Airline Crash 151 9.4.2 Case Report 2: Double Homicide 161 9.5 Conclusions 165 References 166 10 Techniques for the Differentiation of Blunt Force Sharp Force and Gunshot Traumas from Heat Fractures in Burnt Remains 167Hanna Friedlander; Megan Moore and Pamela Mayne Correia 10.1 Introduction 167 10.2 Bone Fracture Biomechanics: Fresh Bone 168 10.3 Bone Fracture Biomechanics: Stages of Thermal Damage 170 10.4 Heat Fractures 171 10.5 Blunt Force Trauma in Burnt Remains 172 10.6 Sharp Force Trauma in Burnt Remains 175 10.7 Gunshot Trauma in Burnt Remains 177 10.8 Case Study: 3D Modelling of Traumatic and Heat Fractures in Cranial and Irregular Bone 179 10.9 Discussion 182 10.10 Conclusions 184 Acknowledgments 185 Permissions 185 References 185 Part 3 Analytical Approaches to the Analysis of Burnt Bone 11 Biochemical Alterations of Bone Subjected to Fire 193Sarah Ellingham and Sara C. Zapico 11.1 The Biological and Chemical Makeup of Fresh Bone 193 11.1.1 Introduction 193 11.2 Bone Transformation When Subjected to Heat 195 11.3 Analytical Approaches to Observing Bone Transformation 196 11.3.1 Colorimetry 196 11.3.2 SEM-EDX 196 11.3.3 Fourier Transform Infrared-Spectroscopy 198 11.3.4 Raman Spectroscopy 200 11.3.5 X-Ray Diffraction 201 11.3.6 Thermogravimetric Analysis (TGA) and Differential Scanning Calorimetry (DSC) 202 11.3.7 Amino Acid Racemization 202 11.4 DNA 204 11.5 Changes to the Bone at Different Temperatures 205 11.5.1 100°C Exposure 205 11.5.2 200°C Exposure 206 11.5.3 300°C Exposure 206 11.5.4 400°C Exposure 207 11.5.5 500°C Exposure 207 11.5.6 600°C Exposure 207 11.5.7 700°C Exposure 207 11.5.8 800°C Exposure 208 11.5.9 900°C Exposure 208 11.5.10 1000°C Exposure 208 11.6 Conclusion 208 Acknowledgment 209 References 209 12 DNA Profiling from Burnt Remains 213Sara C. Zapico and Rebecca Stone-Gordon 12.1 Introduction 213 12.2 Research Studies on Burnt Remains 214 12.3 Forensic Cases 218 12.4 Alternative Approaches and New Technologies 221 12.4.1 Assessment of DNA Damage 221 12.4.2 Alternatives for DNA Extraction 222 12.4.3 New Technologies 223 12.5 Conclusions 225 References 226 13 Applying Colorimetry to the Study of Low Temperature Thermal Changes in Bone 229Christopher W. Schmidt and Alexandria McDaniel 13.1 Introduction 229 13.2 Colorimetry 230 13.3 Challenges of Colorimetry 232 13.4 Case Study 233 13.5 Conclusion 236 References 236 14 The Use of Histology to Distinguish Animal from Human Burnt Bone with Reference to Some Limitations 241Pamela Mayne Correia; Kalyna Horocholyn and Kassandra Pointer 14.1 Introduction 241 14.2 Bone Tissue 242 14.2.1 Primary Bone Tissue 243 14.2.2 Secondary Bone 252 14.3 Vertebrate Histology 254 14.4 Burnt Bone Histology 256 14.5 Case Study for Comparison of Histology of Cremated Bone 259 14.5.1 Qualitative and Quantitative Analysis for Case Study 259 14.6 Discussion 264 14.7 Conclusion 266 References 267 15 Isotope Analysis from Cremated Remains 273Christophe Snoeck 15.1 Introduction 273 15.2 Infrared Analyses 274 15.3 Radiocarbon Dating 276 15.4 Isotope Analyses 277 15.4.1 Carbon and Oxygen Isotope Ratios 277 15.4.2 Strontium Isotope Ratios and Concentrations 281 15.5 Archaeological Case Studies 282 15.5.1 Stonehenge 282 15.5.2 Meuse Basin Belgium and the Netherlands 283 15.6 Conclusions 285 Acknowledgments 285 References 285 16 The Application of Imaging to Heat-Induced Bone 291Rachael M. Carew and David Errickson 16.1 Introduction 291 16.2 Technological Progression 292 16.3 The Current Technology 294 16.3.1 Two-Dimensional Imaging 294 16.3.2 Three-Dimensional Imaging 295 16.4 The Application of Imaging to Heat-Induced and Burnt Bodies 299 16.4.1 Locating and Identifying Burnt Bone 299 16.4.2 Visual Capture and Documentation for Recording and Archiving 300 16.4.3 Quantifying and Analyzing Burnt Remains 301 16.4.4 Reconstruction 302 16.4.5 Ethical and Legal Considerations within the Forensic Context 305 16.5 Discussion and Conclusion 306 References 308 17 The First Reference Collection for the Research of Burnt Human Skeletal Remains Stemming from the 21st Century Identified Skeletal Collection (Portugal) 313David Gonçalves; Calil Makhoul; Maria Teresa Ferreira and Eugénia Cunha 17.1 Introduction 313 17.1.1 The Challenge Posed by Burnt Skeletal Remains 313 17.1.2 Changing the Paradigm 315 17.1.3 The 21st Century Identified Skeletal Collection 320 17.1.4 Preparing the Skeletons 321 17.1.5 Composition of the Collection 323 17.2 Research Potential 324 17.3 Final Comments 327 Acknowledgments 328 References 328 Part 4 Case Studies 18 Analysis of Burnt Human Remains: Statistical Perspectives from Casework in Forensic Anthropology 337Douglas H. Ubelaker; Cassandra M. DeGaglia and Haley Khosrowshahi 18.1 Introduction 337 18.2 Materials and Methods 337 18.3 Results 339 18.4 Discussion 342 18.5 Conclusions 344 Literature Cited 344 19 The Challenge of Burnt Remains from the Brazilian “Microwave Oven” 345Melina Calmon Silva; Eugénia Cunha and Yara Vieira Lemos 19.1 Introduction 345 19.2 Brazilian Homicide Rates 346 19.3 The Relationship between Homicide and Drugs 347 19.4 The “Microwave Oven” Modality of Death / Disposability of Human Remains 348 19.4 Phases of Rubber Tire Combustion 350 19.5 The Challenges of Investigating “Microwave Oven” Deaths 351 19.6 The Role of Forensic Anthropology 353 19.6.1 Case Study 1 354 19.6.2 Case Study 2 359 19.7 Conclusion 365 Conflicts of Interest 366 Ethical Approval 366 Acknowledgments 366 References 367 20 Recovery and Identification of Fatal Fire Victims from the 2018 Northern California Camp Fire Disaster 371Colleen Milligan; Alison Galloway; Ashley Kendell; Lauren Zephro; P. Willey and Eric Bartelink 20.1 Overview of the Camp Fire 371 20.2 Wildfire Burn Environments and Condition of Remains 374 20.3 Field to Morgue: What’s Important for Identification Efforts? 375 20.4 Morgue Identification 379 20.5 Conclusions 381 References 381 21 Recovery and Identification of Burnt Remains in a Military Theatre of Operations: The Warrior Six 383Julie Roberts 21.1 Introduction 383 21.1.1 Improvised Explosive Devices and Blast Injuries 384 21.1.2 The Effects of Heat on Bone 384 21.2 Background to the Case 385 21.3 Assessment of the Vehicle and Recovered Remains 387 21.4 Excavation Strategy and Methodology 390 21.5 Examination of the Remains in the Temporary Mortuary 394 21.6 Examinations in the Role 3 Hospital 398 21.6.1 Soldier A 398 21.6.2 Soldier B 398 21.6.3 Soldier C 399 21.6.4 Soldier D 399 21.6.5 Soldier E 400 21.6.6 Soldier F 400 21.7 Post-mortem Examinations and Positive Identification in the UK 401 21.8 Conclusions 403 Acknowledgments 403 References 403 22 Volcanoes Bones and Heat: The Case of the AD 79 Victims of Vesuvius 407Pier paolo Petrone 22.1 Introduction 407 22.2 The AD 79 Eruption of Vesuvius 408 22.3 The Date of the Eruption 410 22.4 Historical and Archaeological Context of the Discovery 411 22.5 Bioarchaeological and Taphonomic Study 413 22.6 The Causes of Death 418 22.7 The Most Recent Studies 420 22.8 An Exceptional Discovery 427 22.9 Conclusions 430 References 431 Index 437

Read more less

Book SynopsisTable of ContentsPreface xi Acknowledgments xii About the Companion Website xiii Chapter 1 Research Ethics: The Best Ethical Practices Produce the Best Science 1 Judge yourself 6 Morality vs. ethics 6 Onward and upward 8 Inauspicious beginnings 8 How science works 10 Nothing succeeds like success 13 Summary 14 Chapter 2 How Honest Is Science? 15 Judge yourself 16 Sanctionable research misconduct: fabrication, falsification, and plagiarism 16 “Scientists behaving badly” 17 Do scientists behave worse with experience? 20 Judge yourself 20 Crime and punishment 21 Judge yourself 25 Discussion questions 27 Summary 28 Chapter 3 Research Misconduct: Plagiarize and Perish 29 Ideas 31 Sentences 32 Phrases 32 A hoppy example 33 What is plagiarism, really? 34 Judge yourself 34 How many consecutive identical and uncited words constitute plagiarism? 35 Self- plagiarism and recycling 36 Judge yourself 37 Judge yourself 44 Tools to discover plagiarism 46 iThenticate 46 References cited 48 Self- plagiarism and ethics revisited 51 Judge yourself 51 Is plagiarism getting worse? 52 The [true] case study: the plagiarizing novelist who also plagiarized her confession to plagiarism and the author of the website “Plagiarism Today” 54 Summary 55 Chapter 4 Finding the Perfect Mentor 56 Caveat 57 Choosing a mentor 58 Judge yourself 62 Choosing a graduate project 69 Judge yourself 69 Mentors for assistant professors 69 How to train your mentor 75 Discussion questions 78 Discussion questions 80 Summary 81 Chapter 5 Becoming the Perfect Mentor 82 Grants and contracts are a prerequisite to productive science 84 Judge yourself 85 Publications are the fruit of research 86 On a personal level 87 Judge yourself 88 Common and predictable mistakes scientist make at key stages in their training and careers and how being a good mentor can make improvements 88 Discussion questions 104 Summary 105 Chapter 6 Research Misconduct: Fabricating Data and Falsification 106 Why cheat? 107 Judge yourself 110 The case of Jan Hendrik Schön, “Plastic Fantastic” 110 The case of Woo- Suk Hwang: dog cloner, data fabricator 111 The case of Diederik Stapel, psychological serial fabricator 113 Judge yourself 114 Detection of image and data misrepresentation 116 Judge yourself 120 Lessons learnt 121 Summary 121 Chapter 7 Research Misconduct: Falsification and Whistleblowing 122 Reporting and adjudicating research misconduct 123 A “can of worms” indeed: the case of Elizabeth “Betsy” Goodwin 125 Judge yourself 128 Judge yourself 129 Judge yourself 131 Judge yourself 137 Judge yourself 140 Cultivating a culture of openness, integrity, and accountability 140 Summary 141 Chapter 8 Publication Ethics of Authorship: Who Is an Author on a Scientific Paper and Why 142 The importance of the scientific publication 143 Predatory publishing 145 Judge yourself 146 Who should be listed as an author on a scientific paper? 146 Judge yourself 150 How to avoid authorship quandaries and disputes 151 Authorship for works other than research papers 153 The difference between authorship on scientific papers and inventorship on patents 154 Other thoughts on authorship and publications 155 Judge yourself 157 Summary 162 Chapter 9 Grant Proposals: Ethics and Success Intertwined 163 Why funding is crucial 164 Judge yourself 168 Path to success in funding 168 Fair play and collaboration 170 Judge yourself 171 Judge yourself 173 Recordkeeping and fiscal responsibility 173 Pushing the limits on proposals 174 Summary 179 Chapter 10 Peer Review and the Ethics of Privileged Information 180 The history of peer review 181 The nature of journals and the purpose of peer review 182 Open- access journals vs. subscription journals 182 Which papers to review? 188 Open reviews and discussion 189 Judge yourself 190 Grant proposals 190 Confidentiality and privileged information 191 Reviewers 192 Judge yourself 192 Final thoughts 193 Summary 195 Chapter 11 Data and Data Management: The Ethics of Data 196 Stewardship of data 197 Judge yourself 199 Judge yourself 204 Judge yourself 208 The land of in- between: ethics of data presented at professional meetings 208 Judge yourself 213 Raw data, processed data, and data analysis: ways to go right and wrong 213 Summary 213 Discussion questions 215 Discussion questions 216 Chapter 12 Conflicts of Interest 217 The dynamic landscape of conflicts of interest 218 Potential conflicts of interest for university scientists 219 Judge yourself 226 Conflicts of interest within labs or universities 226 Judge yourself 228 Discussion questions 232 Discussion questions 237 Summary 238 Chapter 13 What Kind of Research Science World Do We Want? 239 A culture of discipline and an ethic of entrepreneurship 241 Judge yourself 243 Too much pressure? 243 Integrity awareness through ethics education 246 Accountability 246 Truth will win 247 We scientists 248 Summary 249 References 250 Index 256

Read more less

Book SynopsisA rich and wonderful history of quinine – the cure for malaria.Trade Review'This engrossing, beautifully crafted history is a parable for our times, I believe, underscoring the foolishness of men, with some rare exceptions, and the munificence of Nature' Adrian Hartley, Spectator 'Absorbing and superbly researched' Miranda Seymour, Sunday Times 'A fascinating account of quinine's key role in the making of the modern world. Many have tried to tell this tale, and it is a testament to Rocco's flair and sheer hard work that she has found new things to say' Gail Vines, Independent 'Fiammetta Rocco's wonderfully elegant book, drawing on previously undiscovered documents, attacks its subject as hungrily as a mosquito detecting its next meal' Philip Blackmore, Catholic Herald

Read more less

Book SynopsisA comprehensive examination of all critical aspects of Disaster Victim Identification (DVI) As the frequency of both natural and man-made mass fatality disasters increases worldwide, the establishment of clear standards and best practices within the field of Disaster Victim identification (DVI) is of vital importance. Whereas most countries assign jurisdiction to law enforcement agencies following Interpol guidelines, DVI is the responsibility of the medical examiner and coroner in the United States. Disaster Victim Identification in the 21st Century is the first book of its kind to directly address the needs of DVI practitioners in the United States, covering the full spectrum of DVI from traditional methods such as fingerprints, odontology, and anthropology to advanced DNA identification technology. Approaching DVI from three perspectivesacademic, government, and private industrythis comprehensive volume examines the history and current state of the discipline, Table of ContentsAbout the Editors xv Notes on the Contributors xvii Preface xxi Series Preface xxiii 1 Introduction 1John A Williams and Victor W Weedn 1.1 Introduction 1 1.2 This Book 3 2 Historical Background 7Victor W Weedn 2.1 History of Mass Disasters 7 2.2 Early History of Mass Disaster Response 14 2.2.1 The Portsmouth Christmas Fires and 1803 Portsmouth Federal Disaster Relief 16 2.2.2 The 1835 Great Fire of New York City 16 2.2.3 1865 Sultana Explosion 18 2.2.4 The 1871 Fires 18 2.2.5 American Red Cross (ARC) 19 2.2.6 1889 Johnstown Flood 19 2.2.7 1899 San Ciriaco Hurricane 20 2.2.8 1900 Galveston Storm 20 2.2.9 1906 San Francisco Earthquake 21 2.2.10 1911 Triangle Shirtwaist Fire 21 2.2.11 1912 Sinking of Titanic 22 2.2.12 1918 Spanish Flu Pandemic 22 2.2.13 1921–22 Russian (Povolzhye) Famine 23 2.2.14 1927 Mississippi River Flood 24 2.3 1930s and 1940s Federal Disaster Relief Legislation 24 2.3.1 World War II Civilian Preparedness and Emergency Assets 25 2.3.2 Post WWII Federal Disaster Relief Legislation 25 2.3.3 Civil Defense Act of 1950 (P.L 81-920) 26 2.3.4 Federal Disaster Relief Act of 1950 (P.L 81-875) 26 2.4 1950s Federal Disaster Relief 28 2.5 1960s Beginnings 28 2.5.1 1960 Hurricane Donna 29 2.5.2 1961 Hurricane Carla 29 2.5.3 1962 Ash Wednesday Storm 29 2.5.4 1964 Great Alaskan Earthquake 30 2.5.5 1960s Federal Activism in the Wake of the Alaskan Earthquake 30 2.5.6 1965 Palm Sunday Tornado Outbreak 30 2.5.7 1965 Hurricane Betsy 31 2.5.8 Disaster Relief Act of 1966 31 2.5.9 1968 National Flood Insurance 31 2.5.10 1969 Hurricane Camille 32 2.6 Disaster Relief Acts of 1969 and 1970 32 2.6.1 1971 San Fernando (Sylmar) Earthquake 32 2.6.2 1972 Hurricane Agnes 33 2.6.3 1974 Super Outbreak 33 2.6.4 Disaster Relief Act Amendments of 1974 33 2.7 National Emergencies Act of 1976 34 2.8 National Earthquake Hazards Reduction Program (NEHRP) of 1977 34 2.9 1979 Executive Orders 12127 & 12148 – Federal Emergency Management Agency (FEMA) 35 2.9.1 1979 Three Mile Island (TMI) Nuclear Accident 36 2.9.2 1980 Mount St Helens Volcanic Eruption 37 2.10 Disaster Relief and Emergency Assistance Act of 1988 (The Stafford Act) 37 2.10.1 FEMA under President George H W Bush (1989–1993) 38 2.10.2 1989 Exxon Valdez Oil Spill 38 2.10.3 1989 Hurricane Hugo 39 2.10.4 1989 Loma Prieta Earthquake 39 2.11 1992 Federal Response Plan (FRP) 40 2.11.1 1992 Hurricane Andrew 40 2.11.2 1992 Hurricane Iniki 41 2.12 FEMA under President William J Clinton (1993–2001) 41 2.12.1 1993 Midwest Floods 42 2.12.2 1994 Northridge Earthquake 42 2.12.3 1995 Oklahoma City Bombing 42 2.13 1996 EMAC 43 2.14 FEMA under President George W Bush (2001–2009) 43 2.14.1 2001 Al Qaeda 9/11 Terrorist Attacks 44 2.15 Department of Homeland Security (DHS) 45 2.15.1 2005 Hurricane Katrina 47 2.16 Post-Katrina Emergency Management Reform Act of 2006 (PKEMRA) 48 2.17 2008 National Response Framework (NRF) 49 2.18 2011 National Disaster Recovery Framework 50 2.18.1 2012 Hurricane Sandy 50 2.18.2 Sandy Recovery Improvement Act of 2013 (SRIA) 50 2.18.3 2017 Hurricane Harvey 51 2.18.4 2017 Hurricane Maria 51 2.19 The Disaster Recovery Reform Act of 2018 (DRRA) 52 2.20 2020 COVID-19 Pandemic 52 2.21 Summary of Federal Disaster Response 53 2.22 History of Disaster Victim Identification 54 2.22.1 Scientific Methods of Identification 55 2.22.2 Military Identification Efforts 59 2.22.3 Fbi Dvi Squad 61 2.22.4 Interpol 61 2.22.5 Other International Guidance 63 2.22.6 Disaster Mortuary Operations Response Team (DMORT) 64 2.22.7 National Association of Medical Examiners 65 2.22.9 US Standards Setting Efforts 66 2.22.8 Federal Direction 65 2.23 Conclusion 68 References 68 3 Quality Assurance in Disaster Victim Identification: The Case for Standards 93Jason M Wiersema and Michal L Pierce 3.1 Introduction 93 3.2 The Need for Standards in MDI 94 3.3 The Need for Standards in DVI 96 3.4 History of Standards Development in DVI 98 3.5 Organization of Scientific Area Committees (OSAC) 99 3.6 Discussion 100 3.7 Adoption of Standards 102 3.8 Conclusion 104 References 104 4 Medical Examiners, Coroners, and Public and Private Agencies 107John A Williams and Jason Wiersema 4.1 Introduction 107 4.2 The Medical Examiner/Coroner System 109 4.3 The US Federal Government and Mass Disasters 111 4.4 Disaster Mortuary Operational Response Team 115 4.5 Transportation Disaster Response 121 4.6 State Reponses to Mass Fatalities 122 4.7 The Private Sector 123 4.8 Summary 123 References 124 5 DVI Morgue Operations 127John A Williams 5.1 Introduction 127 5.2 DVI Morgue Considerations 127 5.2.1 Morgue Site Selection 128 5.2.2 Incident Command System 129 5.3 Workflow in the DVI Morgue 131 5.4 DVI Morgue Stations 135 5.4.1 Non-forensic Stations 135 5.4.2 Forensic Stations 139 5.5 Information Resource Center 141 5.6 Identification and Reconciliation 142 5.7 Summary 143 References 143 6 Forensic Odontology and Disaster Victim Identification 145Kenneth W Aschheim 6.1 Introduction 145 6.2 Methods of Identification of an Individual 145 6.2.1 Non-Dental Methods of Identification 145 6.2.2 Dental Identification 146 6.3 Theoretical Basis for Comparative Dental Analysis 147 6.3.1 Basic Theory 147 6.3.2 The 32 Teeth Concept 149 6.3.3 Logical Direction of Change 151 6.3.4 Comparison Discrepancies 151 6.3.5 Concordant Features 151 6.4 The Antemortem Dental Record 153 6.4.1 Tooth Numbering Systems 154 6.5 Laws Governing the Transfer of Protected Dental Information 155 6.5.1 Electronic Dental Record 156 6.5.2 Issues Concerning Dental Data 156 6.6 The Postmortem Dental Record 156 6.7 The Dental Autopsy 157 6.7.1 Visible Light Fluorescence 159 6.7.2 Craniofacial Dissection 159 6.7.3 Antemortem Radiographs 160 6.7.4 Postmortem Radiographs 161 6.7.5 Types of Imaging Devices 161 6.7.5.1 Film 161 6.7.5.2 Phosphorus Storage Plates (PSP) 162 6.7.6 Digital Sensors 162 6.7.7 Radiographic Sources 162 6.7.8 Types of Dental Radiographs 163 6.7.8.1 Intraoral Radiographs 163 6.7.8.2 Extraoral Radiographs 164 6.7.9 Radiographic Guidelines 166 6.8 Intraoral and Extraoral Photographs 167 6.8.1 Postmortem Photographs 168 6.9 Study Casts 169 6.10 Denture Labeling 170 6.11 Dental Age Assessment 171 6.12 Characterization of Dental Materials 172 6.13 Reconciliation 172 6.13.1 Source Conclusions 172 6.13.2 Serial Unmasking 173 6.13.3 Criteria for Comparison and Reconciliation 173 6.13.4 Reporting 174 6.13.5 Terminology 174 6.14 Assembling the Forensic Odontology Team 174 6.14.1 Leadership Team 176 6.14.2 Administration Team 176 6.14.3 Site Assessment Team 177 6.14.4 Antemortem Team 177 6.14.5 Postmortem Team 178 6.14.6 Coding Team 178 6.14.7 Information Technology Team 178 6.14.8 Photographic Team 178 6.14.9 Reconciliation (Comparison) Team 179 6.14.10 Identification Review Board (IRB) 179 6.15 Computer-Assisted Dental Identification 179 6.15.1 Computer Assisted Post-Mortem Identification (CAPMI) 180 6.15.2 WinID3 181 6.15.3 Uvis/Udim 183 6.15.4 Dvi System International 186 6.15.5 OdontoSearch 187 6.16 Ethical Considerations 188 6.17 Demobilization and After-Action Reports 189 6.17.1 Demobilization 189 6.17.2 Preservation of Dental Data 189 6.17.2.1 Preservation of Antemortem Dental Data 189 6.17.2.2 Preservation of Postmortem Dental Data 190 6.17.3 Post-Action Follow-Up 190 6.17.4 Planning and Training 190 6.18 Conclusion 191 References 191 7 Fingerprints and DVI 195Bryan Johnson 7.1 Introduction 195 7.2 Role of Fingerprints in DVI 197 7.3 The DVI Process and Fingerprints 198 7.4 Postmortem Fingerprinting Station 200 7.5 Personnel and Postmortem Fingerprinting 203 7.6 Postmortem Fingerprinting Process 204 7.6.1 Inspection and Cleansing 205 7.6.2 Rehydration 205 7.6.2.1 Macerated Remains 209 7.6.2.1.1 Tissue Injection 209 7.6.2.1.2 Degloving 210 7.6.2.1.3 Boiling Method 210 7.6.2.2 Thermal Modification (Charred/burned Skin) 213 7.6.2.2.1 Tendon Release 214 7.6.2.2.2 Break and Twist Method 214 7.6.2.3 Desiccation (Mummification) 215 7.6.2.3.1 Sodium Hydroxide Reconditioning 217 7.6.2.3.2 Ammonium Hydroxide Reconditioning 217 7.6.2.3.3 Detergent Soaking Reconditioning 218 7.6.3 Collecting PM Prints 219 7.6.3.1 Digital Capture 219 7.6.3.2 Powder and Adhesive Lifters 220 7.6.3.3 Ink and Paper 222 7.6.3.4 Casting 224 7.6.3.5 Photography 225 7.7 Searching/AM Records 226 7.7.1 Database Searches 227 7.7.2 AM Purported Knowns 228 7.7.3 Palm Prints and Footprints 229 7.8 Conclusion 230 References 231 8 DNA Technology and the Future of Disaster Victim Identification 233Taylor M Dickerson III 8.1 Introduction 233 8.2 STRs and Mini-STRs 235 8.3 Lineage Markers 237 8.4 Next Generation Sequencing 240 8.5 Rapid DNA 241 8.6 Conclusion 243 References 243 9 The Victim Information Center and Data Collection: Its Evolving Role in DVI 249Jason H Byrd 9.1 Introduction 249 9.1.1 History of the Family Assistance Center 250 9.2 Overall Function of the Victim Information Center 251 9.2.1 Incident Operations 252 9.2.2 Meeting the Needs of Families and Survivors 253 9.2.3 Briefings and Communication 254 9.3 Components of the Victim Information Center 255 9.3.1 Temporary Reception Center 255 9.3.2 Call Centers 255 9.3.2.1 Missing Persons Call Center 256 9.3.2.2 Air Carrier Call Center 256 9.4 Accounting for the Victims 257 9.4.1 Victim Information Program 257 9.5 Considerations for the Victim Information Center 259 9.5.1 Equipment and Personnel 259 9.5.2 Function and Location 261 9.5.3 Closing the Victim Information Center 262 9.6 Available Resources 263 References 264 10 Ethical and Legal Considerations 265Victor W Weedn 10.1 Introduction 265 10.2 State Authority for Fatality Management 265 10.3 Federal Medicolegal Death Investigations 267 10.3.1 Assassination of the President or Other Federal Officials 267 10.4 Legislatively Mandated Scientific Identification 267 10.5 Missing Persons Acts and Presumptive Deaths 268 10.6 Rights of the Dead 269 10.7 Rights of Others in the Dead 269 10.8 Constitutional Considerations in Responding to Disasters 270 10.9 Emergency Powers 271 10.10 Stafford Act 271 10.11 Federal Executive Administration 274 10.12 State and Local Executive Administration 276 10.13 Military Assistance 276 10.14 Transportation Incidents 278 10.15 Terrorist Incidents 279 10.16 Infectious Epidemics 279 10.17 National Emergency Family Registry and Locator System/National Call Center 280 10.18 International Legal Considerations in DVI 281 10.18.1 The US Department of State 281 10.18.2 Nation-specific Laws 281 10.18.3 Obligation to Identify Victims 282 10.18.4 International Disaster Response Law 283 10.18.5 International Treaties 284 10.18.6 International Humanitarian Law 286 10.18.7 International Human Rights Law 287 10.18.8 Missing and Disappeared Treaties 288 10.18.9 International Resources 288 10.18.10 Aviation and Maritime Deaths 290 10.18.11 Presumed Deaths 291 10.18.12 Customs 292 10.18.13 Telecommunications 292 10.18.14 International Framework for Risk Reduction 292 10.19 Ethical Considerations in DVI 293 10.19.1 Community Resilience 295 10.19.2 Equal Treatment 296 10.19.3 Respectful Treatment of the Remains 296 10.19.4 Respect for the Beliefs of the Deceased 296 10.19.5 Respect for Loved Ones 296 10.19.6 Respectful Communications 297 10.19.7 Haitian Example [184–186] 297 10.20 Conclusion 298 References 299 11 DVI in the Changing Twenty-first Century 313Cynthia S Gavin 11.1 Introduction 313 11.2 Trend Analysis 314 11.2.1 Megatrend #1: Population Shift and Megacity Growth 315 11.2.2 Megatrend #2: Change in Disaster Types that Result in MFIs 315 11.2.3 Megatrend #3: Massive Technological Advancement 318 11.2.4 Megatrend #4: Social Media and Social Expectations 320 11.2.5 Megatrend #5: The Specialization of Ethics 321 11.2.6 Megatrend #6: A New Dynamic Disaster Management System 322 11.2.7 Megatrend #7: A New DVI Model 323 11.2.8 Megatrend #8: Healthcare and the National and International Privatization of Medicine 325 11.3 Forcefield Analysis 326 11.3.1 Drivers of Change: Regulation and Legal Factors 326 11.3.2 Drivers and Constrainers of Change: Politics 328 11.3.3 Constrainers of Change 332 11.3.4 A Neutral Context to Gain Insight regarding Driving and Constraining Forces 337 11.4 DVI Futures in the Twenty-first Century 339 11.4.1 The Quantum Forensics World 340 11.4.2 The Modern Crowners World 341 11.4.3 The Launch-Resistant Forensics World 342 11.4.4 The Hey Buddy Innovator World 342 11.5 Future DVI Strategy Performance 343 11.5.1 DVI Strategies 343 11.5.2 Stress-Testing Strategies Against DVI Futures 344 11.6 SWOT Analysis 350 11.6.1 Strengths 350 11.6.2 Weaknesses 351 11.6.3 Opportunities 351 11.6.4 Threats 352 11.7 Actionable Recommendations 352 11.7.1 Refresh the ME/C Mission Statement 352 11.7.2 Create an Enduring DVI Vision 354 11.7.3 Envision a Future Smart Independent Regional Forensic Science System and Move Toward Implementing This Model 356 11.7.4 Develop Alternate DVI Standards 358 11.8 Closing Thoughts 360 References 362 Index 371

Read more less

Book SynopsisThousands of methods have been developed in the various biomedical disciplines, and those covered in this book represent the basic, essential and most widely used methods in several different disciplines. Table of Contents1: Detection And Analysis Of Proteins A. Introduction B. Basic methods for protein analysis C. Characterization of primary, secondary, tertiary and quaternary structures of proteins 2: Detection And Analysis Of Nucleic Acids A. Introduction B. Basic methods for nucleic acid analysis C. DNA sequencing D. Detection and quantitation of RNA 3: Recombinant DNA Techniques: Cloning And Manipulation Of DNA A. Introduction B. Plasmid and viral vectors C. Libraries D. Site Directed Mutagenesis E. Polymerase chain reaction (PCR) F. Screening for differentially expressed genes (DEGs) G. Promoter-protein interactions H. Silencing gene expression I. Forensics and DNA technology 4: Antibody-Based Techniques A. Introduction B. Monoclonal antibodies C. Purification and use of antibodies D. Flow cytometry and fluorescence activated cell sorting (FACS) E. Other assays using antibodies 5: Microscopy: Imaging Of Biological Specimens A. Introduction B. Light microscopy C. Fluorescence and laser confocal microarray microscopy D. Electron Microscopy (EM) E. Magnetic resonance imaging (MRI) 6: The Derivation And Manipulation Of Experimental Animals In Biomedical Sciences A. Introduction B. Inbred strains of mice C. Congenic strains of mice D. Transgenic mice E. Targeted transgenes: 'knockout' and 'knockin' mice F. Other uses of mice in biomedical research References Some excellent methodology manuals Index

Read more less